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Abstract  
iii 
This thesis investigates the metabolic and cellular effects of carbohydrate-based 
preconditioning drinks in humans. Previous studies have demonstrated that 
preoperative carbohydrate loading, as opposed to overnight fasting, attenuated 
the development of postoperative insulin resistance by up to 50% and led to 
clinical benefits. Preconditioning with carbohydrate-based drinks was 
incorporated into enhanced recovery after surgery programs. The latter included 
interventions that aimed to minimise metabolic-stress and hasten recovery 
after major surgery. However, the cellular mechanisms underlying the adverse 
effects of preoperative fasting and the beneficial effects of preconditioning with 
carbohydrate-based drinks were hitherto unknown. In healthy volunteers, short-
term fasting (up to 24 hours) reduced liver volume, depleted liver glycogen (-
50%) and lipid reserves, and increased intramyocellular lipid concentrations 
(+23%), as measured by magnetic resonance spectroscopy. Changes in liver 
glycogen were partially reversed following ingestion of a carbohydrate-based 
drink that also contained glutamine and antioxidants (ONS, Fresenius Kabi, 
Germany). Fasting also led to significantly decreased blood mononuclear cell 
mitochondrial complex activity. In patients undergoing laparoscopic 
cholecystectomy, preoperative conditioning with ONS, compared to ingestion of 
a placebo-drink, significantly increased intraoperative liver glycogen by 50%, 
increased intraoperative plasma glutamine and antioxidant concentrations, led 
to lower expression of skeletal muscle pyruvate dehydrogenase kinase 4 mRNA 
and protein expression, and finally, reduced cellular oxidative stress, as indicated 
by a 1.5-fold lower expression of metallothionein-1A in the ONS group. Ingestion 
iv 
of ONS led to markedly differing hormonal and metabolic responses compared 
to those following a clear carbohydrate drink (preOp®, Nutricia Clinical Care, 
UK), with blunted postprandial glucose and insulin responses following ONS. 
Supplementing preOp® with glutamine blunted postprandial insulin and 
glucose responses but this was not due to differences in glucagon-like peptide-1 
concentrations. Finally, the gastric emptying of these drinks was more 
dependent on carbohydrate content than macronutrient composition or 
osmolality. 
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Chapter 1  
Introduction 
2 
Recent studies have demonstrated that preoperative fasting induces metabolic 
stress and leads to postoperative insulin resistance which results in 
hyperglycaemia. The latter may cause increased infective complications, 
morbidity and mortality. Measures aimed at decreasing perioperative insulin 
resistance, such as the avoidance of preoperative fasting by giving patients 
carbohydrate-based drinks up to 2 hours preoperatively, may lead to clinical 
benefits. However, the mechanisms that underlie the development of 
perioperative insulin resistance during fasting and its attenuation by 
preoperative conditioning with carbohydrate-based drinks are yet to be defined. 
Understanding these mechanisms would allow the optimisation and 
improvement of interventions designed to reduce insulin resistance. This 
Chapter reviews and discusses the adverse effects of short-term (up to 36 hours) 
fasting, the development of insulin resistance and its clinical significance, the 
evidence base that relates to preoperative carbohydrate loading and the 
mechanisms that may link mitochondrial dysfunction to the development of 
insulin resistance. 
 
1.1 Search strategy 
Searches of the Medline (Ovid, PubMed, Embase) and Science Citation Index 
databases, and the GoogleTM search engine were performed using the key words 
metabolic, stress, metabolism, hormones, insulin, insulin resistance, insulin 
sensitivity, starvation, fast, preoperative, postoperative, surgery, anaesthesia, 
3 
outcome, complication, carbohydrate, feed, load, mitochondria, oxidative stress 
and reactive oxygen species in various combinations with the Boolean operators 
AND, OR and NOT. Animal and human studies published in the last 30 years and 
key earlier articles were included. Articles published in languages other than 
English, those published only in abstract form and case reports were excluded. 
Key journals, textbooks on nutrition and metabolism, and the reference lists of 
key articles were also hand searched. 
 
1.2 Metabolic regulation and the development of insulin resistance during 
fasting and surgery 
The regulation of the bodys energy reserves is crucial to survival and is brought 
about by metabolic pathways controlled by a number of hormones, the most 
important being insulin and glucagon (Table 1.1).  
 
Table 1.1: Hormones involved in the metabolic regulation of the bodys energy 
reserves (Frayn, 1999; Allison and Go, 2004). 
Hormone Metabolic effects 
Insulin Carbohydrate metabolism: inhibits glycogenolysis, stimulates 
glycogenesis, inhibits gluconeogenesis, stimulates glycolysis, 
stimulates muscle and fat cellular glucose uptake  
Protein metabolism: decreases protein catabolism, increases 
amino acid uptake 
4 
Fat metabolism: stimulates lipogenesis, stimulates uptake of 
fatty acids from plasma triacylglycerol into adipose tissue (via 
lipoprotein lipase), inhibits lipolysis (inhibition of hormone-
sensitive lipase), inhibits fatty acid oxidation, inhibits 
ketogenesis 
Gene expression: control of genes involved in glucose 
metabolism and de novo lipogenesis 
Glucagon Carbohydrate metabolism: stimulates glycogenolysis, 
stimulates gluconeogenesis, inhibits glycolysis  
Protein metabolism: stimulates amino acid catabolism 
Fat metabolism: stimulates fatty acid oxidation, stimulates 
ketogenesis 
Glucocorticoids Carbohydrate metabolism: stimulate gluconeogenesis, inhibit 
muscle glucose uptake 
Protein metabolism: stimulate protein catabolism 
Fat metabolism: stimulate lipolysis  
Noradrenaline/ 
Adrenaline 
Carbohydrate metabolism: stimulate glycogenolysis 
Protein metabolism: stimulate amino acid catabolism 
Fat metabolism: stimulate lipolysis (via hormone-sensitive 
lipase) 
Thyroid 
hormones 
Modulate level of response of body to other hormones, in 
particular, regulate sensitivity of metabolic processes to 
catecholamines 
Protein metabolism: stimulate protein catabolism 
Growth 
hormone 
Carbohydrate metabolism: stimulates hepatic gluconeogenesis 
and glycogenolysis 
Protein metabolism: stimulates protein synthesis 
Fat metabolism: stimulates lipolysis 
 
 
5 
Plasma glucose concentrations are primarily controlled by insulin and glucagon. 
On binding to its cell membrane receptor (Figure 1.1), insulin initiates a signal 
that permits the storage of energy within liver, muscle and adipose tissue 
(Krentz, 2002; Allison and Go, 2004). The facilitative glucose transporter (GLUT-4) 
is of importance in the regulation of the bodys energy reserves by permitting 
the movement of glucose down a concentration gradient across cell membranes. 
Figure 1.1: Signal transduction chain for the metabolic regulation by insulin. The 
insulin-receptor signalling involves two major pathways: the mitogen activated protein 
kinase (MAPK) pathway, which is mainly responsible for mitogenesis and cell growth and 
will not be considered further. The second is the phosphatidylinositol-3-kinase (PI3K) 
pathway which accounts for metabolic responses. Insulin binds to its receptor leading to 
autophosphorylation of tyrosine residues in the receptor protein. This leads to 
interaction with a family of proteins known as insulin receptor substrates (IRS), which 
themselves become phosphorylated and then interact with the enzyme PI3K. PI3K 
6 
generates phosphatidylinositol (3,4,5)-trisphosphate (PIP3) in the inner surface of the 
membrane, which acts through the enzyme 3-phosphotidylinositol dependent kinase-1 
(PDK1) to phosphorylate (and active) protein kinase B (PKB, also known as Akt). 
Activated PKB leads to several cellular responses to insulin including inhibition of 
lipolysis, increased glucose transport, effects on DNA transcription, and phosphorylation 
and inactivation of glycogen synthase kinase 3 (GSK3). Inactivation of GSK3 also leads to 
multiple cellular effects including stimulation of glycogen synthesis, effects on gene 
expression and protein chain initiation (i.e. mRNA translation). Copyright © 2003 
Blackwell. From Metabolic Regulation A Human Perspective, Frayn KN, 2nd Edition, 2003. 
Modified with permission from Blackwell publishing. 
 
 
Following the binding of insulin to its receptor, the subsequent intracellular 
signal leads to the translocation of intracellular GLUT-4-rich vesicles to the cell 
membrane (Krentz, 2002). This increases the amount of GLUT-4 transporters 
available for glucose transport into the cell. By contrast, glucagon acts mainly on 
the liver to increase plasma glucose concentration. A fall in plasma glucose 
concentration will, therefore, lead to a decreased ratio of plasma insulin to 
glucagon, the net effect being elevation of blood glucose concentration. 
  
1.2.1 Body fuel reserves 
Carbohydrate is stored as glycogen with only skeletal muscle and the liver having 
sufficient glycogen reserves to fulfil bodily needs. Skeletal muscle comprises 40% 
of body weight and contains around 350-400 g of glycogen (15 g/kg muscle) 
7 
(Frayn, 1999). As muscle lacks the enzyme glucose-6-phosphatase, this store of 
glycogen cannot be released into the circulation as glucose. Instead, muscle 
utilises glycogen to release glucose precursors (lactate, pyruvate and/or alanine) 
that are used by the liver for gluconeogenesis (Frayn, 1999). The cycle whereby 
lactate, produced by anaerobic glycolysis in muscle, moves to the liver where it is 
converted to glucose, which returns to muscles and is converted back to lactate, 
is termed the Cori cycle.  Liver glycogen reserves are more readily available in the 
form of glucose and play the major role of buffering glucose concentrations. 
The liver glycogen content varies and is dependent on factors such as diet and 
exercise, but is typically around 50-120 g (50-80 g/kg liver). 
 
1.2.2 Energy metabolism interactions  
The post-absorptive state is typically represented by the situation after an 
overnight fast. Plasma glucose concentration is just under 5 mmol/L and the 
concentration of insulin is typically around 9 mIU/L. At this time, plasma 
concentrations of glucose and insulin are at the nadir of the 24-hour cycle and 
glucose enters the blood almost exclusively from the liver following both 
glycogenolysis and gluconeogenesis. Gluconeogenic substrates consist of lactate 
(from sources including muscle, erythrocytes and the renal medulla), alanine 
(from muscle) and glycerol (from adipose tissue). Much of the glucose thus 
produced is taken up by the brain. The low concentrations of glucose and insulin 
result in little uptake of glucose by non-neuronal tissue, net breakdown of 
8 
protein by skeletal muscle, liberation of fatty acids from adipose tissue (lack of 
restraint of the insulin-sensitive hormone lipase) and ketone body formation 
(provides fuel for muscle, brain and adipose tissue). The liberated fatty acids 
become the preferred fuel for muscle, thus sparing any plasma glucose for use 
by brain, erythrocytes and the renal medulla i.e. obligatory glucose-utilising 
tissues (Frayn, 1999; Allison and Go, 2004). 
Food intake, digestion and absorption stimulate pancreatic release of insulin. The 
resultant increase in the insulin:glucagon ratio switches hepatic glycogen 
metabolism from breakdown to synthesis, reduces the release of fatty acids from 
adipose tissue and increases glucose uptake by skeletal muscle. The decrease in 
plasma fatty acid concentration and increase in glucose uptake reduces the drive 
for muscle to oxidise fatty acids. There follows an increase in glucose oxidation 
with increased production of lactate and pyruvate (due to increased glycolysis), 
increase in muscle glycogenesis and net protein synthesis (Frayn, 1999; Allison 
and Go, 2004). The increased substrate supply also stimulates hepatic 
gluconeogenesis and glycogenesis. The increase in insulin concentration also 
drives esterification and storage of fatty acids as triacylglycerol in adipocytes.  
 
1.2.3 Metabolic effects of short-term fasting 
As liver glycogen stores are virtually depleted within 24 hours (Rothman et al., 
1991), gluconeogenesis supplies the requirements of the brain and other 
9 
glucose-requiring tissues. The low insulin:glucagon ratio and the increased 
supply of gluconeogenic substrates stimulates gluconeogenesis. Falling insulin 
concentrations lead to both net proteolysis in muscle, with release of alanine 
and glutamine, and lipolysis in adipose tissue, with release of glycerol and non-
esterified fatty acids (NEFA). The increased availability of NEFA directly 
stimulates muscle oxidation of fat rather than glucose. Gluconeogenesis at this 
stage proceeds at the expense of muscle protein but given that the brain 
requires around 100-120 g of glucose/day, the rate of muscle protein breakdown 
could be rapid, up to 210 g protein/day  as not all amino acids can be converted 
to glucose, around 1.75 g of muscle protein must be broken down to provide 1 g 
of glucose (Hill, 1992; Frayn, 1999; Allison and Go, 2004). 
 
1.2.4 Perioperative reduction in insulin sensitivity  
Impaired insulin sensitivity or insulin resistance signifies a state of reduced 
peripheral and hepatic responsiveness to the biological actions of insulin (Allison 
and Go, 2004). Approximately 25% of normal individuals and up to 85% of type 2 
diabetic populations are insulin resistant (Lebovitz, 2002). Insulin resistance is 
regarded as the major metabolic anomaly underlying the group of diseases that 
comprise the metabolic syndrome [type 2 diabetes, obesity, dyslipidaemia, 
hypertension, hypercoagulability and non-alcoholic steatohepatitis] (Krentz, 
2002; Lebovitz, 2002) and it also occurs transiently after starvation, trauma and 
surgery (Wolfe et al., 1979; Black et al., 1982; Krentz, 2002; Nygren, 2006).  
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There are two main sites of insulin resistance: peripheral tissue (mainly skeletal 
muscle) and the liver. The former contributes to the development of early 
postoperative insulin resistance (vide infra). Hepatic insulin resistance, on the 
other hand, is an important underlying cause of the metabolic syndrome 
(Leclercq et al., 2007) whereby central obesity is thought to act as a source of 
free fatty acids, reactive oxygen species (vide infra), tumour necrosis factor and 
other adipokines that impair insulin action in the liver (Leclercq et al., 2007). 
Furthermore, hepatic insulin resistance has been demonstrated to be present 3 
days after surgery (Soop et al., 2004). The mechanisms and pathways underlying 
the development of hepatic insulin resistance, mainly within the context of the 
metabolic syndrome, have been previously reviewed (Leclercq et al., 2007) and 
will not be considered further.  
Studies in patients with insulin resistant states such as type 2 diabetes have 
demonstrated the development of insulin resistance in muscle to be attributed 
to decreased insulin-stimulated muscle glycogen synthesis, which appears to be 
at least partly due to defects in glucose uptake via GLUT-4 transporters 
(Shulman, 1999). Both raised plasma fatty acid concentrations and defects in 
mitochondrial function (vide infra) are associated with intramyocellular 
accumulation of lipid metabolites. These lead to defective GLUT-4 activity by 
abolishing insulin activation of IRS-1-associated phosphatidylinositol 3-kinase 
activity (Figure 1.1), thus interfering with insulin-mediated activation of GLUT-4 
(Petersen and Shulman, 2006). In healthy volunteers a marked reduction in 
insulin sensitivity occurs after short-term (1-3 days) fasting (Newman and 
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Brodows, 1983; Nygren et al., 1997a; Svanfeldt et al., 2003). Although the 
cellular mechanisms underlying the development of postoperative insulin 
resistance following short-term fasting remain to be elucidated (vide infra), the 
increased levels of plasma fatty acids (Nygren et al., 1997a) and reduction in 
insulin-stimulated glucose uptake (Mansell and Macdonald, 1990; Nygren et al., 
1997b) suggest that such impairment in glucose metabolism may also result from 
defective GLUT-4 activity.  
A reduction in insulin sensitivity also occurs as part of the metabolic response to 
stress such as trauma (Black et al., 1982), burn injury (Wolfe et al., 1979) and 
sepsis (Little et al., 1987; Carlson, 2004). More recently, a number of studies 
have demonstrated a reduction of up to 50% in insulin sensitivity (Nordenstrom 
et al., 1989; Brandi et al., 1990; Ljungqvist et al., 1994; Thorell et al., 1994; 
Nygren et al., 1998a; Nygren et al., 1998b; Soop et al., 2001) following 
uncomplicated elective surgery in healthy non-diabetic patients. Seven healthy 
patients were studied before and 24 hours after elective open cholecystectomy 
(Nordenstrom et al., 1989). Compared with a control group of 5 patients 
undergoing elective inguinal hernia repair, but subjected to an otherwise almost 
identical perioperative care protocol, the cholecystectomy group had 
significantly increased postoperative plasma concentrations of glucose (15%) and 
insulin (50%). These were associated with significant reductions in glucose 
transport (35%) and insulin-stimulated lipogenesis (50%) in isolated fat cells 
(Nordenstrom et al., 1989). Another study of 7 patients (Brandi et al., 1990) with 
a normal glucose-tolerance test before and after uncomplicated elective left 
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colonic resection demonstrated postoperatively the hallmarks of surgery-
induced hypercatabolism (increased protein oxidation and energy expenditure), 
associated with increased plasma concentrations of counter-regulatory 
hormones (cortisol, glucagon, prolactin and growth hormones) and urinary 
output of catecholamines. These changes were associated with an eight-fold 
increase in insulin needed to maintain euglycaemia during 24 hours of parenteral 
nutrition compared to preoperative requirements. Furthermore, 24 hours of 
insulin supplementation during parenteral nutrition normalised glucose 
oxidation, restrained lipolysis and preserved protein stores. However, in a study 
of 10 patients undergoing elective open cholecystectomy (a moderate surgical 
stress), there was a 54% reduction in insulin sensitivity on the first postoperative 
day, as determined by hyperinsulinaemic-euglycaemic clamps (Thorell et al., 
1994). A further study of 16 patients undergoing elective open cholecystectomy 
(Thorell et al., 1996b), using the same anaesthetic and surgical protocol as the 
aforementioned study (Thorell et al., 1994), reported a slight but significant 
increase in plasma concentrations of noradrenaline and glucagon, but no 
increase in the concentrations of other counter-regulatory hormones 
(adrenaline, growth hormone and cortisol) on the first postoperative day. 
However, it is possible that the sampling time points (basal, postoperative day 1, 
day 5 day 9 and day 20) in the aforementioned study (Thorell et al., 1994) may 
have missed earlier peaks in the concentrations of these hormones. Thus the 
role played by these hormones in the aetiology of postoperative insulin 
resistance remains unclear. 
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Hepatic and muscle insulin resistance and increased reliance on fat oxidation 
have been observed in burn (Wolfe et al., 1979) and septic (Little et al., 1987; 
Agwunobi et al., 2000; Carlson, 2003; Carlson, 2004) patients. A study that 
examined the impact of surgical stress on intermediary metabolism in 9 patients 
undergoing major abdominal surgery (Brandi et al., 1993) found similar changes 
following uncomplicated elective surgery. This insulin resistance was associated 
with both a reduction in peripheral glucose uptake (Thorell et al., 1999a) and 
non-oxidative glucose disposal (mainly glycogen synthesis) (Brandi et al., 1993; 
Thorell et al., 1999a). The contribution of reduced energy intake and bed rest to 
the development of perioperative insulin resistance was examined in another 
study that compared 7 patients undergoing moderate to major abdominal 
surgery with 6 healthy volunteers who had a similar period (24 hours) of rest and 
reduced energy intake (Nygren et al., 1997b). During insulin infusion, 20-30% 
reductions in insulin-stimulated glucose uptake were found as a response to 24 
hours of bed-rest and reduced energy intake in healthy controls. Another study 
later reported that it was reduced energy intake but not bed-rest that resulted in 
a decline in peripheral insulin sensitivity (Nygren et al., 1997a). Reduced insulin 
sensitivity was related to the magnitude of the operation performed (Thorell et 
al., 1993) and persisted for up to 3 weeks postoperatively in another study of 10 
patients undergoing elective open cholecystectomy (Thorell et al., 1994). The 
degree of postoperative insulin resistance was shown to correlate with length of 
postoperative hospital stay in a retrospective analysis of data pooled from a 
number of Swedish studies over a period of 6 years (r2=0.28, P=0.0001, N=60) 
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(Thorell et al., 1999b). Multiple regression analysis of these data found that type 
of surgery (major or minor operation), perioperative blood loss and 
postoperative insulin resistance were independent predictors of length of 
hospital stay. The overall predictive value of this regression model was 71%. 
Furthermore, the presence of postoperative hyperglycaemia, a consequence of 
insulin resistance, has been found to increase postoperative mortality and 
morbidity significantly (van den Berghe et al., 2001; Van den Berghe et al., 2003). 
In a study of intensive insulin therapy in 1548 patients (87% of whom did not 
have a history of diabetes) admitted to a Belgian ICU (63% of the admissions 
followed cardiac surgery), the presence of hyperglycaemia (mean morning blood 
glucose level of 8.5 mmol/L in patients treated in the conventional therapy 
group) was associated with significantly increased ICU mortality (8% versus 
4.6%), increased in-hospital mortality (10.9% versus 7.2%), increased septic 
complications (7.8% versus 4.2%) and prolonged mechanical ventilation (median 
12 versus 10 days), when compared to patients who were randomised to an 
intensive insulin regimen to maintain normoglycaemia [mean morning blood 
glucose level of 5.7 mmol/L] (van den Berghe et al., 2001). The improvement 
associated with intensive insulin therapy is thought (Vanhorebeek et al., 2007) to 
result from the prevention of glucose-induced toxicity to the mitochondria 
(Vanhorebeek et al., 2005), endothelium (Langouche et al., 2005) and immune 
cells (Weekers et al., 2003) and not the insulin dose per se (Vanhorebeek et al., 
2007). 
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1.2.5 Cellular pathways involved in the development of perioperative insulin 
resistance 
To date no studies have examined the cellular and molecular pathways leading 
to the development of perioperative insulin resistance. However, valuable 
insights may be gained from studies of the effects of fasting and refeeding on 
carbohydrate and fat oxidation; and those of other physiological states 
associated with insulin resistance, such as type 2 diabetes, obesity and the 
metabolic syndrome.  
The adaptive changes in skeletal muscle metabolism following fasting increase 
fat oxidation and decrease carbohydrate oxidation (COX), thus conserving 
glucose in times of limited supply (Mansell and Macdonald, 1990; Webber et al., 
1994). The decrease in COX is mediated by a decrease in the activity of the 
mitochondrial enzyme pyruvate dehydrogenase complex [PDC] (Sugden et al., 
1993). PDC has a key role in muscle metabolism as it controls the entry of 
carbohydrate-derived pyruvate into the tricarboxylic acid cycle (Figure 1.2). 
Regulation of the activity of PDC is therefore an important component of glucose 
homeostasis, whereby activation of PDC promotes glucose disposal and 
suppression conserves glucose (Sugden et al., 2001).  
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Figure 1.2: Regulation of pyruvate dehydrogenase complex (PDC) activity. PDC 
controls the entry of carbohydrate-derived pyruvate into the tricarboxylic acid (TCA) 
cycle. It is regulated by pyruvate dehydrogenase kinase 4 (PDK4) and increased 
concentrations of NADH and acetyl-CoA, which inactivate PDC, thereby inhibiting 
carbohydrate oxidation. Increased oxidation of free fatty acids (FFA) induces the nuclear 
translocation of forkhead transciption factor (FOXO1) and increases the generation of 
NADH, both of which act to upregulate PDK4 expression and inhibit PDC, thereby linking 
the processes of carbohydrate and fat oxidation. Increased FFA oxidation also increases 
generation of reactive oxygen species (ROS) which induce the activation of FOXO1 and 
upregulate the expression of metallothionein-1A (Mt-1A). Increased concentrations of 
FFA also act to interfere with insulin signalling pathways, via effects on IRS-1 and protein 
kinase B (PKB), see Figure 1.1, leading to decreased PDC activity. Finally inhibition of PDC 
activity increases the diversion of pyruvate to oxaloacetate (via the enzyme pyruvate 
carboxylase, PC) leading to increased citrate formation, the latter suppressing glucose 
uptake and glycolysis. 
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PDC is regulated by pyruvate dehydrogenase kinase (PDK) which phosphorylates 
and inactivates PDC thereby inhibiting COX. Of the four isoforms of PDK, PDK4 is 
the one predominantly expressed in human skeletal muscle (Spriet et al., 2004). 
PDK4 is thought to be a lipid-status-responsive PDK isoform facilitating fatty 
acid oxidation by sparing pyruvate for oxaloacetate formation (Sugden et al., 
2001). In skeletal muscle, increased diversion of pyruvate to oxaloacetate 
facilitates the entry of acetyl-CoA derived from fatty acid β-oxidation into the 
TCA cycle leading to citrate formation. The latter acts as a signal of fatty acid 
abundance that suppresses glucose uptake and glycolysis (Sugden et al., 2001). 
The activity of the PDKs is regulated by both end-product inhibition by the 
common products of glucose and fatty acid metabolism (acetyl-CoA and NADH), 
and the opposing effects of intermediates of metabolism (Sugden and Holness, 
1994; Sugden et al., 2001). Examples of the latter include the acute suppression 
of PDK activity by pyruvate and conversely the acute activation of PDK by the 
high concentration ratios of acetyl-CoA to CoA and of NADH to NAD+ in the 
mitochondria following increased rates of β-oxidation (Sugden and Holness, 
1994; Sugden et al., 2001). PDK4 expression is also regulated by forkhead 
transcription factor-1, FOXO1, (Furuyama et al., 2003) which acts to mediate the 
effects of insulin action on gene expression (Accili and Arden, 2004). In the liver, 
FOXO1 also promotes the transcription of genes that increase glucose 
production (Accili and Arden, 2004).  
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Previous studies (Sugden et al., 1993; Wu et al., 1999; Pilegaard et al., 2003; 
Spriet et al., 2004; Tsintzas et al., 2006) have demonstrated that 15-48 hour 
periods of fasting resulted in increased expression of PDK4, increased PDK 
activity and decreased PDC activity. The aforementioned changes may have 
resulted from increased availability of circulating free fatty acids (FFA), which 
induce the nuclear translocation of the FOXO1 (via the IRS-1/PKB pathway, 
Figure 1.2). FOXO1 can bind directly to the promoter region of the PDK4 gene 
thereby mediating the upregulation of PDK4 mRNA (Furuyama et al., 2003). In 
support of this hypothesis, animal studies have demonstrated the fasting-
induced upregulation of FOXO1 mRNA and protein expression (Furuyama et al., 
2003), although human studies have failed to demonstrate this (Tsintzas et al., 
2006). Similarly, studies have demonstrated conflicting findings regarding the 
role played by Akt in insulin resistance pathways (Kim et al., 1999; Kruszynska et 
al., 2002; Brozinick et al., 2003). The increased cellular availability of FFA also 
augments the rate of FFA oxidation thereby leading to increased mitochondrial 
long-chain acyl-CoA oxidation and increased ROS generation. Given that ROS can 
induce the activation of FOXO in cell lines (Nakamura and Sakamoto, 2008) and 
have been implicated in the development of insulin resistance (Evans et al., 
2002; Houstis et al., 2006), the measurement of indicators of oxidative stress, 
such as metallothionein-1A (Mt-1A) (Nath et al., 2000), pentanes (Aghdassi and 
Allard, 2000) or products of lipid peroxidation (Niki, 2008), could offer further 
insights into the mechanisms that induce perioperative insulin resistance.  
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1.3 Preoperative fasting and carbohydrate loading 
Current elective surgical practice is to fast patients for 6 hours for solids and 2 
hours for clear liquids preoperatively, which is based on historical concerns of 
increased risks of aspiration of stomach contents during anaesthesia (Maltby, 
2006). However, delays and changes in operating schedules result in patients 
being fasted for longer periods  even up to 18 hours (Diks et al., 2005). The 
dogma of preoperative fasting has been challenged recently and both animal 
(Ljungqvist et al., 1986; Ljungqvist et al., 1987; Ljungqvist et al., 1990; Esahili et 
al., 1991; Alibegovic and Ljungqvist, 1993; Friberg et al., 1994; Bark et al., 1995; 
Nettelbladt et al., 1997; van Hoorn et al., 2005a; van Hoorn et al., 2005b) and 
human (Newman and Brodows, 1983; Jensen et al., 1987; Fryburg et al., 1990; 
Gallen et al., 1990; Rothman et al., 1991; Webber and Macdonald, 1994; Webber 
et al., 1994; Samra et al., 1996; Nygren et al., 1997a; Nygren et al., 1997b; 
Nygren et al., 1998b; Tsintzas et al., 2006) studies have demonstrated adverse 
metabolic effects caused by preoperative fasting. 
 
1.3.1 Preoperative fasting: History and current guidelines 
The history behind the dogma of preoperative fasting has been reviewed 
comprehensively (Maltby, 2006). It appears that the adoption and blanket 
imposition of the nil per os (NPO) from midnight guideline for healthy patients 
undergoing elective surgery, without due distinction between solids and liquids, 
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arose following transfer of principles of emergency anaesthesia to elective 
practice, incorrect deductions from the results of animal experiments and the 
perceived ease (Maltby, 2006) with which such guidelines could be followed in 
clinical practice. 
In the last two decades a number of clinical studies have challenged the 
traditional belief that all healthy patients undergoing elective surgery should be 
NPO from midnight. A meta-analysis of these studies concluded that intake of 
oral liquids was safe until 2 hours before general anaesthesia (Soreide et al., 
1997). A Cochrane review of 22 trials with 2270 participants similarly found that 
amongst healthy, non-pregnant, adult patients undergoing elective surgery, 
there were no reported cases of aspiration/regurgitation and no evidence of a 
difference in residual gastric volume or pH of gastric contents when a shortened 
fluid fast (90-180 min preoperatively) was compared with a standard fast (NPO 
from midnight) (Brady et al., 2003). Furthermore, the volume of fluid intake did 
not have an impact on participants gastric volume or pH when compared to a 
standard fast. Even in patients with co-morbid conditions (American Society of 
Anaesthesiologists grade IV/V) undergoing emergency surgery, aspiration 
occurred infrequently and mortality was low (1:71,829) (Warner et al., 1993).  
Current guidelines from various national anaesthetic societies permit a light meal 
(dry toast and clear liquid) not less than 6 hours before surgery and unrestricted 
clear liquids (water, fruit juice without pulp, carbonated drinks, clear tea and 
black coffee) until 2 hours before surgery (Soreide et al., 1997; Smith, 2006). The 
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intake of these fluids is, however, unlikely to have a major effect on the 
metabolic state of the body which remains in the fasted state. Recently, several 
authors (Ljungqvist, 2004; Nygren, 2006) have raised concerns about performing 
surgery in the metabolically-stressed state after overnight fasting, especially as 
surgery itself causes severe catabolic stress (Moore, 1959; Cuthbertson, 1980b; 
Cuthbertson, 1980a). Thence followed a number of experiments that compared 
the effects and outcomes of undergoing surgery in the fasted and fed states.  
 
1.3.2 Animal studies on the metabolic effects of preoperative fasting 
Evidence that short-term fasting has adverse effects on the metabolic and 
haemodynamic responses to stress was clear from rat experiments dating back 
to 1945 (Diks et al., 2005). Compared to fasted rats, fed rats were found to lose 
less nitrogen and have a better haemodynamic response following experimental 
haemorrhage. Numerous investigators (Table 1.2) further studied the effects of 
fasting and feeding prior to exposure to various stresses on mortality (Ljungqvist 
et al., 1987; Esahili et al., 1991; Alibegovic and Ljungqvist, 1993), liver glycogen 
metabolism (Ljungqvist et al., 1990; Alibegovic and Ljungqvist, 1993), endocrine 
responses (Ljungqvist et al., 1990), skeletal muscle function (Friberg et al., 1994) 
and enteric bacterial translocation (Bark et al., 1995; Nettelbladt et al., 1997). 
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Table 1.2: Animal studies investigating the effects of fasting prior to surgical stress. Adapted and updated with permission  
from Diks et al (Diks et al., 2005). Abbreviations: ADMA, asymmetrical dimethylarginine; GSH, glutathione; IL-6, interleukin-6;  
IR, ischaemia-reperfusion; MDA, malondialdehyde; MPO, myeloperoxidase. 
 
Study Study groups Stress 
Variable(s) 
examined 
Results 
(Ljungqvist et al., 
1987)  
Fed versus 24-
hour fast, then 
stress 
Haemorrhage Glucose 
concentrations, 
7-day survival 
Hyperglycaemia developed in fed but not in 
fasted rats. All fed rats survived, whereas all 
fasted rats died. 
(Esahili et al., 1991)  Fed versus 24-
hour fast, then 
stress 
Endotoxin 
challenge 
(intravenous or 
intraperitoneal) 
7-day survival Fasting associated with 210 - 240% higher 
mortality in intravenously-treated group and 
190 - 200% higher mortality in 
intraperitoneally-treated group. 
(Alibegovic and 
Ljungqvist, 1993)  
24-hour fast 
followed by either 
30% glucose or 
0.9% saline 
Haemorrhage  7-day survival, 
liver glycogen 
concentrations 
All fasted animals died within 3 hours post-
haemorrhage, but all fed animals (given 
glucose infusion pre-haemorrhage) recovered. 
Liver glycogen concentrations were 600% 
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infusion, then 
stress 
higher in the fed group. 
(Friberg et al., 1994)  Fed versus 24-
hour fast, then 
stress 
Haemorrhage Muscle function After 24-hour fast there was loss of muscle 
strength, even before exposure to 
haemorrhagic shock. After haemorrhage 
muscle strength lower in fasted group. 
(Bark et al., 1995)  Fed versus 24-
hour fast, then 
stress 
Haemorrhage Presence of 
enteric bacteria 
in mesenteric 
lymph nodes  
Incidence of mesenteric lymph nodes with 
enteric bacteria was higher in fasted rats 
(P<0.05) and the numbers of bacteria was 
greater (P<0.01). 
(Nettelbladt et al., 
1997)  
Fed versus 24 and 
48-hour fast 
1. Fasting only 
2. Haemorrhage 
Number of 
coliform bacteria 
in caecum, 
bacterial 
adherence to 
epithelium 
24 and 48-hour fasts increased number of 
coliform bacteria in caecum by a factor of 25 
and 100, respectively. Increase in bacterial 
adherence to intestinal epithelium by factor of 
3000. 
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(van Hoorn et al., 
2005b) 
 
Fed versus 16-
hour fast  
 
 
Intestinal 
ischaemia-
reperfusion 
model 
Liver glycogen 
concentration, 
myeloperoxidase 
activity, reduced 
& oxidised tissue 
glutathione, 
ADMA 
concentration, 
IL-6 
concentration 
Liver glycogen concentration significantly 
lower (48.2%) in fasted rats than in fed rats. 
Lung myeloperoxidase activity significantly 
lower in fed group than fasted group. Lung 
GSH concentration significantly higher in fed 
group.  Fed GSH concentration almost 
retained at level of sham fasted animals. 
Fed group had significantly lower ADMA and 
IL-6 concentrations compared to fasted 
animals. 
(van Hoorn et al., 
2005a) 
 
Fed versus 13-
hour fast 
 
 
 
Intestinal 
ischaemia-
reperfusion 
model 
Organ function & 
vitality, severity 
of oxidative 
stress, energy 
status of liver & 
intestine 
Heart performance after intestinal IR worse in 
fasted group than in fed group who 
maintained normal values. Markers of 
oxidative stress (MDA concentration) higher in 
intestine & lungs of fasted animals.  Lower 
ATP/ADP in liver & intestine of fasted animals. 
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These studies proved that the metabolic state (fed versus fasted) of animals prior 
to exposure to stress was related to mortality and other outcomes following the 
stress. Although the underlying mechanisms are yet to be elucidated, a number 
of theories have been proposed. The preservation of liver glycogen stores 
(Ljungqvist et al., 1990; Alibegovic and Ljungqvist, 1993) in fed animals permits 
the rapid release of glucose into the bloodstream (Ljungqvist et al., 1987; 
Alibegovic and Ljungqvist, 1993; Bark et al., 1995) following stresses such as 
experimental haemorrhage. The resultant hyperosmolar state leads to beneficial 
effects on fluid homeostasis by increasing plasma refill, improving heart function 
and increasing peripheral blood flow (Ljungqvist et al., 1986; Ljungqvist et al., 
1990). Furthermore, preservation of liver glycogen is thought to reduce the need 
for mobilisation of muscle glycogen stores (Diks et al., 2005), to enable 
gluconeogenesis, which in turn preserves muscle strength both before and after 
exposure to stress (Friberg et al., 1994; Diks et al., 2005). Recent data also 
suggest that liver glycogen may be of importance in maintaining normal levels of 
antioxidant enzymes (van Hoorn et al., 2005a; van Hoorn et al., 2005b). An 
attenuated endocrine stress response in fed animals (Ljungqvist et al., 1986) 
reduced the ensuing catabolic response (Ljungqvist et al., 1990). Finally, the 
preservation of intestinal energy stores (van Hoorn et al., 2005a) and, therefore, 
integrity of the mucosal barrier, may protect against enteric bacterial 
translocation under conditions of stress (Diks et al., 2005; van Hoorn et al., 
2005a; van Hoorn et al., 2005b). 
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1.3.3 Human studies on the metabolic effects of preoperative fasting 
Few human studies have examined the effects of preoperative fasting on 
morbidity and mortality (Diks et al., 2005). However, the metabolic effects of 
short-term fasting in healthy humans have been well characterised. A decrease 
in insulin sensitivity of peripheral tissues (Newman and Brodows, 1983; Nygren 
et al., 1997a; Tsintzas et al., 2006), regarded as a marker of perioperative 
metabolic-stress (Thorell et al., 1999b), leads to a decrease in muscle glucose 
uptake (Gallen et al., 1990; Mansell and Macdonald, 1990; Webber et al., 1994; 
Tsintzas et al., 2006) which is accompanied by a reduction in oxidative glucose 
disposal (Mansell and Macdonald, 1990; Webber and Macdonald, 1994; Nygren 
et al., 1997b) and either a decrease (Nygren et al., 1997b; Nygren et al., 1998b) 
or no change (Mansell and Macdonald, 1990; Webber et al., 1994) in non-
oxidative glucose disposal. An increase in resting energy expenditure occurs due 
to the metabolically more expensive processes of gluconeogenesis and 
ketogenesis (Webber and Macdonald, 1994). Elevations in plasma fatty acid 
concentrations (Samra et al., 1996; Nygren et al., 1997a; Tsintzas et al., 2006) are 
accompanied by decreases in the antilipolytic effects of insulin (Jensen et al., 
1987), although this latter finding has not been reproduced in other studies 
(Newman and Brodows, 1983; Webber et al., 1994). Whole body protein 
catabolism is increased (Fryburg et al., 1990), but in contrast to perturbations in 
fat metabolism, muscle remains sensitive to the antiproteolytic effect of insulin 
(Fryburg et al., 1990). Finally, depletion of liver glycogen stores occurs after as 
little as 24 hours of fasting (Rothman et al., 1991; Thorell et al., 1996; Frayn, 
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1999). The resulting metabolic state where easily utilisable energy is unavailable, 
especially during times of increased metabolic demand, is thought to have a 
detrimental effect on clinical outcome (Soop et al., 2001; Yuill et al., 2005). 
 
1.3.4 Preoperative carbohydrate loading versus fasting 
The aforementioned studies demonstrated that an insulin resistant, 
metabolically-stressed state can result from even short periods of fasting. 
Furthermore, animal studies showed a clear benefit from being in a fed as 
opposed to a fasted state at the onset of stress (Nygren et al., 2001). Therefore, 
a number of human studies (Ljungqvist et al., 1994; Nygren et al., 1995; Nygren 
et al., 1998a; Nygren et al., 1999; Hausel et al., 2001; Soop et al., 2001; 
Henriksen et al., 2003; Bisgaard et al., 2004; Soop et al., 2004; Svanfeldt et al., 
2005; Yuill et al., 2005; Breuer et al., 2006; Melis et al., 2006; Svanfeldt et al., 
2007) explored the possibility that preoperative feeding, instead of fasting, 
enabled a more favourable metabolic response to stress such as surgery (Table 
1.3). 
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Table 1.3: Studies investigating the effects of carbohydrate loading versus fasting prior to surgery. Abbreviations: CHO, carbohydrate; 
EGP, endogenous glucose production; FFA, free fatty acids; GIR, glucose infusion rate; ICU, intensive care unit; IR, insulin resistance; LOS, 
length of stay; NEFA, non-esterified fatty acids; Preop, preoperative; Postop, postoperative; WGD, whole-body glucose disposal. 
 
Study Study groups 
Variable(s) 
examined 
Results Limitations of studies 
 
(Ljungqvist 
et al., 1994) 
 
Patients undergoing 
elective open 
cholecystectomy receive 
either glucose infusion 
[Glucose 200 mg/ml, 5 
mg/kg/min] (N=6) or no 
infusion (N=6) during 
preoperative fasting. 
Insulin sensitivity 
measured before surgery 
and on first postop day. 
Glucose, 
insulin & 
stress 
hormone 
concentratio
ns, insulin 
sensitivity 
Postop glucose concentrations elevated in 
both groups but insulin concentrations 
elevated only in control group. No differences 
on postop stress hormone concentrations 
between two groups. Postop insulin sensitivity 
reduced by 55% in control group versus 32% in 
glucose group (P<0.01). 
Small number of patients 
studied. Allocation by date of 
birth (not computer 
generated randomisation 
codes). No information on 
whether preoperative 
carbohydrate ingestion was 
controlled prior to measuring 
insulin sensitivity. Insulin 
sensitivity measured on day 1 
postop. thereby potential 
confounding by effects of 
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postoperative fasting and 
bed rest. Sampling time point 
of hormone measurements 
(day 1 postop) may have 
missed an earlier peak in 
concentrations on operative 
day. 
(Nygren et 
al., 1995) 
Patients undergoing 
elective laparoscopic 
cholecystectomy (N=11) 
and parathyroid surgery 
(N=1). Randomised to 400 
ml CHO rich drink [285 
mOsm/kg, 12% CHO] 
(N=6) or 400 ml water 
(N=6) 4 hours before 
induction of anaesthesia. 
Gastric 
emptying 
rate, insulin 
& glucose 
concentratio
ns 
 
Despite presence of anxiety and hunger on 
morning of surgery, oral CHO drink leaves 
stomach within 90 min of ingestion. In CHO-
drink group elevated insulin concentrations 40 
min after ingestion mimicked those produced 
by intravenous administered glucose infusions 
(Ljungqvist et al., 1994). 
Only ASA grade I/II patients 
studied and these are not 
representative of everyday 
patients. Method of 
allocation of patients to 
study groups not stated. 
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(Thorell et 
al., 1996a) 
Patients undergoing 
elective open 
cholecystectomy receive 
either glucose infusion 
[Glucose 200 mg/ml, 5 
mg/kg/min] (N=8) or no 
infusion (N=8) 
preoperatively. 
Hormonal 
and FFA 
responses to 
surgery, liver 
glycogen 
concentratio
ns 
Preoperative FAA concentrations lower in 
glucose group. CHO loading had little effect on 
stress hormone response to surgery but 
maintained liver glycogen concentrations (65% 
higher than in control group). 
Allocation to study group by 
date of birth. 
(Nygren et 
al., 1998b) 
Patients undergoing 
elective hip surgery. 
Randomised to undergo 
surgery with (N=7) or 
without (N=6) 
hyperinsulinaemic, 
euglycaemic clamp. Insulin 
sensitivity assessed 
before, during and 
Body 
metabolism, 
insulin 
sensitivity & 
endocrine 
responses 
Plasma FAA higher in control group during 
surgery and postop. Cortisol concentrations 
decreased by 65% in insulin group postop but 
not in control group. Comparing preop and 
postop concentrations, no change seen in GIR 
or WGD in insulin group compared to 
decreases in GIR and WGD in control group. 
Glucose oxidation lower and fat oxidation 
higher during and after surgery in control 
Method of allocation of the 
small number of patients to 
study groups not stated. 
Uneven gender distribution 
in study groups. No 
information on whether 
preoperative carbohydrate 
ingestion was controlled 
prior to measuring insulin 
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immediately after surgery. group. sensitivity. Insulin clamps 
performed at different time 
points in study and control 
groups.  EGP not measured. 
(Nygren et 
al., 1999) 
Patients undergoing 
elective colorectal (N=14) 
and hip surgery (N=16). 
Patients were randomised 
to receive CHO (800 ml of 
12.5% iso-osmolar drink 
on evening before 
operation and 400 ml 2 
hours before anaesthesia) 
or placebo drink 
preoperatively. In hip 
group insulin sensitivity 
measured 1 week preop 
Insulin 
sensitivity, 
glucose 
kinetics 
In patients undergoing hip surgery, 37% 
reduction (P<0.05) in insulin sensitivity 
postoperatively in fasted group whereas no 
reduction seen in CHO group. In patients 
undergoing colorectal surgery, 24.3% greater 
reduction in insulin sensitivity postoperatively 
in fasted group compared to CHO group 
(adjusted for confounding variables). Relative 
reduction in WGD after colorectal surgery 
greater in fasted compared to CHO group (-
49% versus -26%, P<0.05). 
No information on whether 
preoperative carbohydrate 
ingestion was controlled 
prior to measuring insulin 
sensitivity. Confounding of 
measurements of postop day 
1 insulin sensitivity in 
colorectal group due to 
hypocaloric nutrition and bed 
rest. Study did not examine 
clinical outcomes such as 
length of hospital stay. 
32 
and immediately postop. 
In colorectal group insulin 
sensitivity measured the 
day before surgery and 24 
hours postop. 
(Soop et al., 
2001) 
Patients undergoing 
elective hip surgery 
(N=15). Randomisation 
(double-blinded) to preop 
CHO drink [800 ml of 
12.5% iso-osmolar drink 
on evening before 
operation and 400 ml 2 
hours before anaesthesia] 
(N=8) or placebo drink 
(N=7). Insulin sensitivity 
measured 1 week preop 
Glucose 
kinetics & 
substrate 
utilization, 
insulin 
sensitivity 
 
CHO group had lower concentrations of 
glycerol and NEFA preoperatively after 
ingestion of drink. Postop decreases in GIR and 
WGD less in CHO group then placebo group (-
18% versus -43%, P<0.05) and (-19% versus -
37%, P<0.05), respectively. CHO group had 
significantly increased glucose oxidation rates 
that persisted into postop period. Non-
oxidative glucose disposal failed to increase 
postop in both groups in response to insulin 
infusion. 
Method of allocation not 
stated. Small number of 
patients studied. Differences 
in EGP not determined. 
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and immediately after 
surgery to avoid 
confounding effects of 
reduced calorie nutrition 
and bed rest. 
(Hausel et 
al., 2001) 
Consecutive patients 
undergoing elective 
laparoscopic 
cholecystectomy (N=174) 
and major colorectal 
surgery (N=78). 
Randomised to 3 groups: 
Preop CHO drink, preop 
placebo drink and fasted 
from midnight. CHO and 
placebo groups were 
double-blinded. CHO 
CHO-drink 
related 
complication
s, 
residual 
gastric 
volume, 
gastric 
acidity, preop 
discomfort 
 
No cases of pulmonary aspiration or drink-
related complications. Median residual gastric 
fluid volumes similar in all 3 groups (CHO 20ml, 
placebo 20 ml and fasted 22 ml). Gastric pH 
similar in all 3 groups. CHO group had 
increased preop well-being compared to 
placebo and fasted groups. CHO drink relieved 
preop thirst, hunger, anxiety and malaise. 
Method of allocation to study 
groups not stated. Only ASA 
I/II patients studied. RGV 
measured by double lumen 
NG tube. No data on 
outcomes such as length of 
hospital stay  despite large 
number of participants 
studied. 
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group received 800 ml of 
12.5% iso-osmolar drink 
on evening before 
operation and 400 ml 2 
hours before anaesthesia. 
(Henriksen 
et al., 2003) 
Patients undergoing 
elective colorectal surgery 
(n=48) were randomised 
to 3 groups: preop CHO 
drink, preop CHO-peptide 
drink and preop fasting 
(allowed to drink water). 
Patients in intervention 
groups given 800 ml of the 
intervention drink the 
evening before and 400 ml 
3 hours before 
Residual 
gastric 
volumes 
(N=29), 
muscle 
glycogen 
concentratio
ns and 
glycogen 
synthase 
activity, 
voluntary 
No differences in residual gastric volume 
between groups. Although no differences were 
detectable in muscle glycogen concentrations 
between the groups, postop glycogen synthase 
activity was significantly decreased in the 
control compared to the intervention groups. 
Voluntary quadriceps muscle strength did not 
differ between the groups when analysed per 
se but pooled analysis of results from the 2 
intervention groups showed significantly 
better muscle strength one month postop 
compared to control group. No changes in 
Only ASA I/II patients 
studied. RGV measured using 
dye dilution technique.  
Analysis was not intention to 
treat. Data on length of 
hospital stay not given. 
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anaesthesia. CHO drink 
contained 12.5 g CHO/100 
ml. CHO-peptide drink 
contained 12.5 g CHO/100 
ml and 3.5 g hydrolyzed 
soy protein/100 ml. 
strength, 
nutritional 
intake, 
ambulation, 
fatigue, 
anxiety, 
discomfort, 
endocrine 
response 
thirst, hunger, anxiety and overall well-being. 
(Soop et al., 
2004) 
Patients undergoing 
elective hip surgery. 
Randomisation (double-
blinded) to preop CHO 
drink (800 ml of 12.5% iso-
osmolar drink on evening 
before operation and 400 
ml 3 hours before surgery) 
Insulin 
sensitivity 3 
days postop, 
nitrogen 
balance in 
first 3 days 
postop, 
ambulation 
EGP significantly lower and attenuated after 
surgery in CHO group compared to placebo 
group. Relative reduction in GIR on day 3 did 
not differ between groups. 
Nitrogen loses lower in CHO group than 
placebo group (difference of 25 mg/kg/day) 
but overall no difference in nitrogen balance. 
No differences in postop ambulation. 
Only studied small number 
ASA I/II patients. No 
information on whether 
preoperative carbohydrate 
ingestion was controlled 
prior to measuring insulin 
sensitivity. 
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(N=8) or placebo drink 
(N=6). Insulin sensitivity 
assessed 1 week preop 
and day 3 postop. 
Cumulative nitrogen 
balance calculated from 
end of surgery to day 3 
postop. 
(Bisgaard et 
al., 2004) 
Patients undergoing 
elective laparoscopic 
cholecystectomy. 
Randomisation (double-
blinded) to preop CHO 
drink [800 ml of 12.5% iso-
osmolar drink on evening 
before operation and 400 
ml 2 hours before surgery] 
Well-being, 
appetite, 
fatigue, pain, 
nausea & 
vomiting on 
day 1 postop, 
sleep quality 
and physical 
activity 
No cases of apparent or suspected pulmonary 
aspiration or other drink-related 
complications. No inter-group differences in 
scores of well-being, fatigue, appetite, nausea, 
vomiting, analgesic and antiemetic 
requirements, sleep quality or activity levels. 
Pain scores remained significantly raised for 4 
days postop in CHO group. 
Only ASA I/II patients 
studied. Excluded patients if 
more than 5 h elapsed 
between intake of beverage 
and initiation of anaesthesia. 
Excluded patients who 
developed postoperative 
complications. Study sample 
size calculated for a 
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(N=43) or placebo drink 
(N=43). 
secondary (not primary) 
endpoint. No intention to 
treat analysis. 
(Yuill et al., 
2005) 
Patients undergoing 
elective major upper 
gastrointestinal surgery. 
Randomisation (double-
blinded) to preop CHO 
drink [800 ml of 12.6% iso-
osmolar drink on evening 
before operation and 400 
ml 2-3 hours before 
anaesthesia] (N=31) or 
placebo drink (N=34). 
Tolerance 
and effects of 
preop CHO 
loading, 
effects on 
body 
composition, 
length of 
hospital stay 
No instances of perioperative aspiration. At 
hospital discharge no differences in changes in 
endogenous fat reserves but loss of muscle 
mass significantly greater in control group. 
Trend towards reduced LOS in CHO group. 
Anthropometry 
measurements used to 
determine body composition, 
no coefficient of variation 
given for these 
measurements. Analysis not 
intention to treat. No data on 
postoperative ambulation or 
nutrition provided. 
Postoperative glucose 
sensitivity not measured. 
(Svanfeldt 
et al., 2005) 
 
Healthy volunteers (N=6) 
underwent 4 protocols in 
a randomised (unblinded) 
Insulin 
sensitivity 
following 
GIR significantly higher when CHO drink was 
given in morning compared to protocols 
without a morning dose. GIR not affected by 
Preoperative carbohydrate 
ingestion was not controlled 
prior to measuring insulin 
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crossover manner. 
Protocols designed to 
mimic perioperative 
situation: Control group 
was fasted, one CHO 
group given 800 ml of 
12.6% iso-osmolar CHO 
drink on the evening 
before the day of the 
clamp study, second CHO 
group given 400 ml of 
12.6% iso-osmolar CHO 
drink on the morning of 
the clamp study, last CHO 
group given 800 ml of 
12.6% iso-osmolar CHO 
drink on the evening 
before and another 400 
different 
CHO 
regimens 
the drink being given in the evening prior to 
the clamp study. Non-oxidative glucose 
disposal higher when drink had been ingested 
in morning. Insulin action enhanced by 50% 
three hours after ingestion of a morning dose 
of the CHO drink. 
 
sensitivity. Unblinded study. 
No reference for sample size 
estimate calculation. EGP not 
measured. 
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ml on the morning of the 
clamp study. 
(Melis et al., 
2006) 
Patients undergoing 
elective orthopaedic 
surgery. Randomisation 
(blinded) to 3 groups: 
Control group (N=10) was 
fasted from midnight and 
2 groups (N=10 in each) 
were given 2 different 
CHO beverages consumed 
4 hours before surgery. 
Cellular 
immune 
function, 
fluid 
homeostasis, 
thirst, 
hunger, 
nausea, 
anxiety & 
weakness 
No incidents of pulmonary aspiration occurred. 
HLA-DR expression decreased significantly 
after surgery in control group where as no 
change was observed in CHO groups.  Fasted 
patients experienced more thirst preop than 
CHO groups. No difference in other measures 
of well-being. 
No information on allocation 
concealment. Study dinks 
served in glasses (not opaque 
bottles). Primary versus 
secondary outcomes not 
stated. Groups not 
comparable for age and 
gender (confounding variable 
for one of study outcomes). 
(Breuer et 
al., 2006) 
ASA III-IV patients 
undergoing elective 
cardiac surgery (including 
type 2 diabetic patients). 
Randomized to 3 groups: 
Postop 
insulin 
requirement, 
residual 
gastric 
No differences in insulin requirements or 
residual gastric volumes between the different 
groups. No drink-related complications. CHO 
group experienced less thirst than control 
group but no differences in hunger, nausea, 
Primary endpoint of study 
was a surrogate marker 
(insulin requirement) of 
postop insulin resistance. 
RGV estimated by passive 
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preop CHO drink (N=56) 
versus placebo drink 
(N=60) [double-blind] 
versus open-labelled 
control group (N=44) 
fasted from midnight. 
800ml of CHO drink 
(12.5% CHO, isoosmolar) 
or placebo taken evening 
before surgery and 400 ml 
taken 2 hours before 
surgery. Morbidity was 
measured by organ 
dysfunction. 
volume, 
preop 
discomfort, 
drink-related 
complication
s, morbidity 
anxiety and dryness of mouth. CHO and 
placebo groups did not differ in thirst. CHO 
group required less intraoperative inotropes 
after initiation of CPB weaning. No differences 
in severity of illness scores, incidence of 
postop complications and durations of 
hospital/intensive care stay. 
gastric reflux so possibility of 
underestimating GRV. Some 
of outcome variables not 
diagnosed according to 
accepted standards. 
(Svanfeldt 
et al., 2007) 
Patients undergoing 
elective colorectal 
surgery.  Randomisation 
Postop 
whole-body 
protein & 
Postop whole-body protein breakdown higher 
at baseline and during insulin stimulation in 
low CHO group. Surgery evoked more negative 
Small number of patients 
studied. Per protocol (not 
intention to treat) analysis.  
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to receive a preop drink 
with either high 
(125mg/ml, N=6) or low 
(25mg/ml, N=6) CHO load. 
800 ml were ingested 
evening before surgery 
and 600-800 ml were 
taken until 2 hours before 
the estimated time for 
pre-medication. Insulin 
sensitivity assessed 5 days 
preop and on day 1 
postop. 
glucose 
kinetics 
protein balance in low CHO group at baseline 
and during insulin stimulation. No effect of 
CHO on postop insulin sensitivity seen. Postop 
suppression of EGR less effective in low CHO 
group. Positive correlation between EGR and 
whole-body protein breakdown seen after 
surgery (r2=0.432, P=0.02). 
No reference given for 
sample size estimate 
calculation. Long fasting 
durations between 
preoperative serving of study 
drinks and initiation of 
anaesthesia. Carbohydrate 
intakes not standardised in 3 
days prior to insulin-clamp 
measurements. Insulin 
clamps performed on day 1 
post op thus possible 
confounding by postop 
hypocaloric nutrition and 
ambulation. 
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The main objective of these studies on preoperative carbohydrate loading was to 
produce a change in metabolism similar to that occurring after breakfast, 
whereby the endogenous release of insulin turns-off the overnight fasted state 
of metabolism (Ljungqvist and Soreide, 2003). Early studies achieved this through 
the use of intravenous glucose infusions (5 mg/kg/min) and demonstrated a 50% 
reduction in the development of postoperative insulin resistance in the 
carbohydrate-treated groups (Ljungqvist et al., 1994). The high dose of glucose in 
these infusions was necessary to induce a sufficiently high endogenous insulin 
response to change metabolism in the desired way (Ljungqvist et al., 2002) but 
such a dose carried the risk of causing thrombophlebitis (Diks et al., 2005). An 
iso-osmolar drink was developed with sufficient carbohydrate to induce an 
insulin response similar to that after a meal (Ljungqvist et al., 2002) and an 
osmolality that permitted rapid emptying from the stomach (Nygren et al., 
1995). These drinks were shown to empty from the stomach within 2 hours 
(Nygren et al., 1995), with no instances of pulmonary aspiration or other drink-
related complications (Nygren et al., 1995; Nygren et al., 1999; Hausel et al., 
2001; Soop et al., 2001; Henriksen et al., 2003; Bisgaard et al., 2004; Soop et al., 
2004b; Yuill et al., 2005; Breuer et al., 2006; Melis et al., 2006) reported 
following over 6000 patient episodes (Ljungqvist et al., 2002). Furthermore, 
preoperative carbohydrate loading was shown to attenuate the postoperative 
decrease in peripheral (Nygren et al., 1998b; Nygren et al., 1999; Soop et al., 
2001) and hepatic (Soop et al., 2004b; Svanfeldt et al., 2007) sensitivity to insulin, 
maintain hepatic glycogen reserves (Thorell et al., 1996), maintain muscle 
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glycogen synthesis (Henriksen et al., 2003; Svanfeldt et al., 2007), blunt the 
endocrine response to surgery (Nygren et al., 1998b; Nygren et al., 1999), 
attenuate the deterioration in postoperative whole-body protein balance (Yuill 
et al., 2005; Svanfeldt et al., 2007) and muscle function (Henriksen et al., 2003), 
and prevent surgery-induced immunosuppression (Melis et al., 2006). Finally, 
some studies have shown that preoperative carbohydrate loading was associated 
with improved patient well-being with decreased preoperative thirst (Hausel et 
al., 2001; Breuer et al., 2006; Melis et al., 2006), hunger and anxiety (Hausel et 
al., 2001), decreased postoperative nausea and vomiting (Hausel et al., 2005) 
and a 20% reduction in length of hospital stay (Thorell et al., 1999; Ljungqvist et 
al., 2002), although other studies have failed to demonstrate similar effects 
(Henriksen et al., 2003; Bisgaard et al., 2004; Soop et al., 2004a; Yuill et al., 2005; 
Breuer et al., 2006; Melis et al., 2006).  
The majority of the aforementioned studies were undertaken on small numbers 
of patients and although preoperative feeding was associated with beneficial 
physiological effects, such as reduction in perioperative insulin resistance, it is 
yet to be proved conclusively that preoperative carbohydrate loading is 
associated with improved clinical outcomes such as reduction in mortality and 
morbidity. Nonetheless, preoperative carbohydrate feeding is now an accepted 
part of the evidence-based Enhanced Recovery After Surgery (ERAS) program 
which aims to allow patients to recover more quickly from major surgery, avoid 
the sequelae of traditional postoperative care (e.g. decline in nutritional status 
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and fatigue) and reduce healthcare costs by reducing hospital stay (Fearon et al., 
2005).  
Although studies on carbohydrate loading have demonstrated beneficial 
physiological effects, the precise mechanism of action of these drinks is unclear 
(Ljungqvist et al., 2002; Diks et al., 2005). The effects on depleted glycogen 
stores, insulin sensitivity and oxidative stress have already been described but 
the cellular mechanisms that link these processes remain to be elucidated. The 
reduction in perioperative insulin sensitivity in non-diabetic subjects is similar to 
that seen in patients with type 2 diabetes (Ljungqvist et al., 2002). Numerous 
studies on patients with type 2 diabetes have suggested a link between impaired 
mitochondrial function and the development of insulin resistance (Petersen et 
al., 2003; Petersen et al., 2004; Petersen and Shulman, 2006). Thus, it may be 
possible that preoperative carbohydrate loading attenuates the decrease in 
insulin sensitivity by preventing mitochondrial dysfunction (vide infra).  
 
1.3.5 Perioperative glutamine and antioxidant supplementation 
Perioperative glutamine and antioxidant supplementation have been shown to 
improve gastrointestinal perfusion, immune function and morbidity in critically ill 
patients (Houdijk et al., 1998; Jones et al., 1999; Roth, 2001; Bakalar et al., 2006; 
Dechelotte et al., 2006; Berger and Chiolero, 2007). Glutamine is a non-essential 
amino acid that possesses numerous biochemical, metabolic and physiological 
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functions and is required for health. It is a precursor that donates nitrogen for 
the synthesis of purines, pyrimidines, nucleotides and glutathione and is the 
most important substrate for renal ammoniagenesis. Glutamine also serves as a 
nitrogen transporter between various tissues. Finally, it represents the major 
metabolic fuel for enterocytes and many rapidly proliferating cells, including 
those of the immune system. Glutamine is thought to become a conditionally 
essential amino acid during episodes of catabolic stress such as in injury and 
sepsis (Roth, 2001). The effects of enterally administered glutamine were studied 
in a randomised study of 60 patients with multiple trauma [injury severity score 
(Baker et al., 1974) of 20 or more]. Enteral feeds with and without glutamine 
were commenced within 48 hours of hospital admission. There was a significant 
50% reduction in the incidence of pneumonia, bacteraemia and sepsis in the 
glutamine group (Houdijk et al., 1998). In another randomised study of 78 
critically ill intensive care patients, glutamine supplementation of enteral feeds 
led to a significant 30% reduction in hospital patient costs (Jones et al., 1999). 
Parenteral alanyl-glutamine administration resulted in better-maintained glucose 
homeostasis (reduced insulin resistance) following multiple trauma in a 
randomised study of 40 patients (Bakalar et al., 2006). Another randomised 
placebo-controlled study of 114 intensive care patients receiving glutamine-
supplemented parenteral nutrition demonstrated reduced infectious 
complications, hyperglycaemia and insulin requirements in the glutamine-
supplemented group (Dechelotte et al., 2006). Finally, there is evidence that 
preoperative supplementation with immunomodulating nutrients results in 
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significant reductions in postoperative infectious complications (Braga et al., 
1999; Senkal et al., 1999; Snyderman et al., 1999; Tepaske et al., 2001). 
However, the regimens used in the aforementioned studies required 
preoperative supplementation with immunomodulating nutrients 5 to 7 days 
prior to elective surgery which may not be practical in the clinical setting. Other 
groups have suggested that preconditioning with free radical scavengers such as 
ascorbate and vitamins E and A may provide an integrated approach to 
minimizing free radical-induced surgical complications (Baines and Shenkin, 
2002; Orzechowski, 2003; Berger and Chiolero, 2007).  
 
1.4 Mitochondrial function 
Mitochondria produce ATP, serve as biosensors for oxidative stress, and through 
apoptosis, are effector organelles for cell death (Muravchick and Levy, 2006). 
Approximately 98% of inhaled oxygen is consumed by mitochondria (Duchen, 
2004) and the supply of substrates for mitochondrial oxidation is the primary aim 
of ordered food intake, digestion and processing (Duchen, 2004). Disorders in 
mitochondrial function have been implicated in the pathogenesis of a number of 
disease states such as insulin resistance which in turn leads to a number of 
cardiovascular diseases (Petersen et al., 2003). Furthermore, mitochondrial 
dysfunction may lead to increased oxidative stress thus placing many surgical 
patients at increased perioperative risk (Delogu et al., 2001b; Muravchick and 
Levy, 2006). 
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1.4.1 Mitochondrial function in health 
Mitochondria produce the ATP needed for normal cellular function and 
metabolic homeostasis by oxidative phosphorylation (Nelson et al., 2008). This 
process is conducted by a series of five enzyme complexes located on the inner 
mitochondrial membrane (Figure 1.3).  
 
 
 
Figure 1.3: Schematic representation of the components needed for 
mitochondrial oxidative phosphorylation. The electron transport chain is located 
within the inner mitochondrial membrane and is comprised of the oxidase complexes I-
IV, coenzyme Q (Co Q) and cytochrome c (Cyt C). Red arrows are indicative of the 
pathway of electron flow. Complexes I, III and IV pump hydrogen ions (dotted red 
arrows) into the intermembrane space and generate the electrochemical gradient that 
powers the phosphorylation of adenosine diphosphate (ADP) to adenosine triphosphate 
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(ATP) by ATP synthase. H2O, water; NAD, nicotinamide adenine dinucleotide; NADH, 
reduced nicotinamide adenine dinucleotide; O2, oxygen.  
 
 
Four of these complexes comprise the mitochondrial electron transport chain 
(ETC) and function as a biochemical conveyer belt for electrons. These 
electrons are derived from oxidation of glucose or fatty acids and are transferred 
through mitochondrial membrane complexes (MMCs) I to IV via mobile electron 
carriers. At complexes I, III and IV protons are pumped out of the mitochondrial 
matrix into the intermembrane space. This action results in the generation of an 
electrochemical proton gradient which is used by the fifth enzyme complex (ATP 
synthase) to drive ATP synthesis. The ATP produced serves as the currency 
needed for most energy-requiring biological transactions. 
 
1.4.2 Oxidative Stress 
Mitochondrial oxidative phosphorylation is the major intracellular source of 
reactive oxygen species (ROS) or free radicals such as superoxide, peroxide or 
hydroxyl radicals. These ROS are generated as by-products of the interaction 
between free electrons and oxygen (Muravchick and Levy, 2006) and are an 
unavoidable consequence of aerobic metabolism. Free radicals are highly 
reactive molecules that can degrade or destroy mitochondrial enzyme 
complexes, membranes and structural components of cellular microarchitecture, 
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either by direct contact or through lipid peroxidation (Muravchick and Levy, 
2006). Intrinsic defence systems that include superoxide dismutase, catalase, 
glutathione peroxidase, copper, zinc superoxide dismutase and manganese 
superoxide dismutase protect against ROS-induced damage by converting free 
radicals into oxygen and water (Jackson et al., 2002; Muravchick and Levy, 2006). 
Although these endogenous antioxidant defence systems effectively suppress 
ROS concentrations within the cell and mitochondria in health, these 
mechanisms become inadequate in many disease states. Rapid or overwhelming 
increases in ROS produce oxidative stress which can be cytotoxic via initiation of 
apoptosis or disruption of intracellular calcium regulation (Muravchick and Levy, 
2006). 
 
1.4.3 Mitochondrial dysfunction and insulin resistance 
The cellular and molecular mechanisms of insulin resistance have been studied 
extensively with the aim of providing new therapeutic targets for the treatment 
and prevention of type 2 diabetes (Morino et al., 2006). Studies on patients with 
type 2 diabetes have demonstrated glucose transport as the rate-limiting step 
for insulin-stimulated muscle glycogen synthesis. A reduction in the latter was 
the major factor responsible for insulin resistance in these patients (Morino et 
al., 2006). These findings were also demonstrated in healthy insulin-resistant 
offspring of parents with type 2 diabetes suggesting that reduced insulin-
stimulated glucose transport was an early event in the pathogenesis of the 
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disease (Morino et al., 2006). Subsequently, intramyocellular lipid 
concentrations, assessed by 1H magnetic resonance spectroscopy (MRS), were 
found to correlate inversely with muscle insulin sensitivity (Krssak et al., 1999). 
Accumulation of intramyocellular lipid metabolites such as fatty acyl CoAs and 
diacylglycerol resulted from increased delivery of fatty acids from plasma and/or 
reduced mitochondrial β-oxidation. These metabolites activated 
serine/threonine kinases such as protein kinase C which phosphorylated the 
serine residues of IRS-1 leading to defects in insulin signalling, failure of GLUT-4 
translocation and reduced insulin-stimulated glucose uptake (Morino et al., 
2006). Activation of protein kinase C in hepatocytes similarly gave rise to fat-
induced defects in insulin signalling which resulted in reduced insulin stimulation 
of glycogen synthesis and increased hepatic gluconeogenesis (Morino et al., 
2006).  
Further studies have linked defective mitochondrial function with 
intramyocellular accumulation of lipid metabolites and subsequent insulin 
resistance. Petersen et al. (Petersen et al., 2003) matched healthy lean elderly 
volunteers for body mass index and activity with younger subjects. Compared to 
younger controls, elderly subjects had higher concentrations of plasma glucose 
and insulin, a trend towards increased plasma fatty acid concentrations and a 
40% lower rate of insulin-stimulated peripheral glucose uptake. This was 
associated with a 45% and 225% increase in triglyceride concentrations of 
muscle and liver, respectively, as assessed by 1H MRS. In addition, elderly 
subjects had a 40% reduction in the rates of muscle mitochondrial oxidative and 
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phosphorylation activity, assessed by 13C and 31P MRS, respectively. These 
findings suggest that acquired loss of mitochondrial function, associated with 
ageing, may predispose to intramyocellular lipid accumulation, which results in 
insulin resistance through the mechanisms described earlier (Morino et al., 
2006). Similar findings were noted in young lean insulin-resistant offspring of 
parents with type 2 diabetes where severe defects in insulin-stimulated muscle 
glucose metabolism were associated with an 80% increase in intramyocellular 
lipid concentrations and a 30% reduction in rates of mitochondrial ATP 
production (Petersen et al., 2004). 
However, other investigators have suggested that mitochondrial abnormalities 
represent the end result of insulin resistance rather than its cause (Stump et al., 
2003). In this context, reduced insulin action in states of insulin resistance was 
associated with impaired mitochondrial enzyme synthesis and reduced 
mitochondrial oxidative phosphorylation in skeletal muscle (Stump et al., 2003). 
Inducing an insulin deficient state in seven type 1 diabetic patients resulted in 
significantly reduced muscle mitochondrial ATP production capacity which was 
accompanied by an increase in whole body oxygen consumption and alterations 
in transcript levels of genes involved in oxidative phosphorylation (Karakelides et 
al., 2007). Thus reduced insulin action and the associated metabolic changes can 
downregulate muscle oxidative phosphorylation. Another theory is that 
mitochondrial dysfunction in insulin resistance, ageing and type 2 diabetes is a 
reflection of cumulative oxidative stress that involves damage to mitochondrial 
DNA (Ritz and Berrut, 2005). Finally, a study on the effects of intensive insulin 
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therapy on mitochondrial integrity and function in critically ill surgical patients 
demonstrated that hyperglycaemia had a toxic effect on liver, but not muscle, 
mitochondria (Vanhorebeek et al., 2005). Although a limitation of the study was 
that these analyses were performed only in mitochondria of non-survivors, 
abnormalities in mitochondrial ultrastructure were seen in 9% of patients that 
received intensive insulin therapy versus 78% of patients that received 
conventional therapy. Furthermore, the intensive insulin therapy group had 89% 
and 40% higher median activities of MMCs I and IV, respectively. The discrepancy 
in effects on liver and muscle mitochondria was hypothesised to be due to 
different mechanisms of glucose uptake in these organs and suggested that it 
was hyperglycaemia, rather than a direct effect of insulin, that led to the 
aforementioned effects (Vanhorebeek et al., 2005). 
 
1.4.4 Mitochondrial function in fasting 
Although a number of investigators have examined the effects of fasting on 
animal mitochondrial function, this has been within the context of organ 
transplantation and the associated ischaemia-reperfusion injury. Using a murine 
model, Jung and Henke (Jung and Henke, 1993) demonstrated impaired liver 
mitochondrial respiration following 4 days of fasting although this was not 
associated with decreased energy production (quantified by mitochondrial 
concentrations of adenine nucleotide).  
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A study of the effects of nutritional status on rat liver mitochondria 
demonstrated interesting findings in the control group (Vendemiale et al., 2001). 
Mitochondria isolated from rats with normal livers that were fasted for 18 hours 
had greater levels of oxidised lipids and lower concentrations of the ATP 
synthase complex than their fed counterparts. These changes suggested that 
fasting directly caused oxidative injury and decreased mitochondrial ATP 
synthetic capacity. A decrease in mitochondrial ATPase activity, associated with a 
trend towards lower ATP concentrations, was noted in another study of 
orthotopic pig liver transplants following 5 days of fasting (Fukumori et al., 1997). 
However, in this small study (N=5 in each group) the control group was fasted for 
24 hours thus the effects of feeding, as opposed to fasting, on mitochondrial 
function remain unclear.  
A previous group studied the effects of fasting on oxidative balance in 
mitochondria isolated from rat livers in a model of partial hepatic ischaemia-
reperfusion injury (Domenicali et al., 2001). Under baseline conditions, 18 and 
36-hour periods of fasting progressively depleted mitochondrial antioxidant 
stores (glutathione) leading to increased lipid peroxidation. As glutathione stores 
function as cysteine reservoirs, the former are depleted during food deprivation 
(Cho et al., 1981). Fasting also exacerbated mitochondrial oxidative damage 
associated with warm ischaemia-reperfusion injury and this effect was 
dependent on the duration of food deprivation (Domenicali et al., 2001). Finally, 
transmission electron microscopy demonstrated mitochondrial swelling and 
ultrastructural abnormalities during post-ischaemic reperfusion in fasted rats 
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thus providing indirect evidence of membrane injury and mitochondrial 
dysfunction (Domenicali et al., 2001). A study designed to examine the effects of 
fasting on oxidative stress in rat liver mitochondria reported similar findings 
(Sorensen et al., 2006). Compared with overnight fasting in the control group, 
mitochondria of rats fasted for 72 hours showed significantly increased oxidative 
and lipoxidative protein damage (levels of N-malondialdehyde lysine, 
aminoadipic semialdehyde and glutamic semialdehyde in mitochondrial proteins 
of rat liver). Fasting also modified the fatty acid composition of mitochondrial 
membranes. The aforementioned findings suggest that fasting per se adversely 
affects mitochondrial function through increased oxidative stress and generation 
of ROS. These in turn alter the lipid and protein composition of mitochondria 
leading to structural (Domenicali et al., 2001) and functional abnormalities 
(Sorensen et al., 2006).  
A previous study investigated the effects of reduced energy intake on the 
activities of muscle MMCs I to IV and peripheral blood mononuclear cells (PBMC) 
MMC I in rats fed enterally (Briet and Jeejeebhoy, 2001). Compared with 
normally fed rats, one week of protein-energy deprivation significantly reduced 
the activities of complexes I (-73%), II (-68%) and III (-92%) in the mitochondria of 
soleus muscle and complex I     (-74%) in the mitochondria of PBMC. An 
important finding in this study was that the activity of MMC I in PBMC was found 
to correlate with the activity of MMC I in muscle (r2=0.66). The reduction in 
mitochondrial enzyme activities during protein-energy restriction was 
hypothesised (Briet and Jeejeebhoy, 2001) to explain findings of decreased 
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oxygen uptake, substrate oxidation and ADP phosphorylation noted in previous 
studies of the effects of reduced energy intake on oxidative phosphorylation by 
liver and muscle mitochondria (Ferreira and Gil, 1984; Ardawi et al., 1989). This 
hypothesis was subsequently proven in a study of the effects of reduced energy 
intake on mitochondrial function, where decreased activity of complexes I 
(approximately -57%) and III (approximately -51%) correlated with a reduction 
(approximately -57%) in oxidative phosphorylation rate in rat muscle 
mitochondria (Madapallimattam et al., 2002). Studies of human PBMC MMC 
activity similarly demonstrated reduced complex I activity in malnourished 
patients compared to controls (Briet et al., 2003a; Briet et al., 2004). However, 
the effects of fasting on mitochondrial oxidative phosphorylation remain unclear 
as the aforementioned studies were performed in animals and malnourished 
patients who were receiving some energy, albeit not enough to meet daily 
requirements. 
There are no reported human studies on the effects of preoperative fasting on 
perioperative mitochondrial function, the majority being studies on 
mitochondrial function within the context of insulin resistant states such as type 
2 diabetes and obesity. However, given that fasting induces a state of insulin 
resistance, valuable insights into the effects of fasting may be gained from these 
studies. Fasting (Frayn, 1999; Tsintzas et al., 2006) and other states of insulin 
resistance (McGarry, 2002) are associated with elevation in the plasma 
concentration of NEFA. Elevated NEFA concentrations result in increased fatty 
acid flux through skeletal muscle mitochondria which results in reduced 
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mitochondrial oxidative phosphorylation (Sparks et al., 2005), increased ROS 
generation (Jackson et al., 2002) and subsequent mitochondrial dysfunction 
(Sparks et al., 2005)j. In a study that examined the effects of eating a high fat diet 
in humans and mice, the increased flux of fatty acids through muscle was found 
to down regulate genes that encoded mitochondrial proteins and transcription 
factors involved in mitochondrial biogenesis [the process by which mitochondria 
increase their ability to make ATP by synthesizing additional enzyme complexes] 
(Sparks et al., 2005). Interestingly, a similar pattern of gene expression to that 
seen after intake of a high fat diet was induced by short-term fasting in other 
studies (Jagoe et al., 2002; Sparks et al., 2005). Furthermore, these changes 
became more pronounced with increasing length of food deprivation. These 
results may explain the significant fasting-induced decrease in mitochondrial 
protein content noted in earlier studies (Brady and Hoppel, 1983).  
Recent studies have also characterised the effects of insulin on skeletal muscle 
mitochondrial function (Boirie, 2003). Insulin was found to stimulate 
mitochondrial protein synthesis (Boirie et al., 2001), activate mitochondrial 
enzyme activity (Boirie et al., 2001) and stimulate oxidative phosphorylation by 
increasing mitochondrial mRNA transcript expression, protein synthesis, 
activities of cytochrome C oxidase and citrate synthase, and ATP production 
(Stump et al., 2003). Given these findings, it may be hypothesised that a 
reduction in insulin concentration and an increase in NEFA concentration, as 
seen in fasting (Tsintzas et al., 2006), leads to reduced mitochondrial function 
and oxidative capacity (Figure 1.4).  
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Figure 1.4: Potential mechanisms that may link starvation and mitochondrial 
function to the development of insulin resistance. Abbreviations: FA  fatty acid 
flux, NEFAs  non-esterified fatty acids, GLUT4  the facilitative glucose transporter 4. 
 
 
This, in turn, may contribute to a diminished ability to oxidize fatty acids (Blaak 
et al., 2006) leading to intramyocellular fat accumulation (Johnson et al., 2006) 
which, as previously discussed, has been linked to the development of skeletal 
muscle insulin resistance. 
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1.4.5 Perioperative mitochondrial dysfunction 
A study that examined the effects of surgery and anaesthesia on mitochondrial 
function in lymphocytes from 16 patients undergoing major abdominal surgery 
(Delogu et al., 2001b), demonstrated a significant increase in mitochondrial ROS 
production coupled with a significant depletion (-24%) of mitochondrial 
antioxidant (glutathione) stores. These changes in mitochondrial function, 
although transient, were associated with a significant increase in the rate of 
apoptosis amongst CD4+ and CD8+ lymphocytes. Similar findings were noted by 
the same group in a study on perioperative polymorphonuclear neutrophil 
mitochondrial function (Delogu et al., 2001a). These studies suggest that an 
increase in mitochondrial oxidative stress during the perioperative period may 
play a role in mediating the immune suppression that is seen after surgery 
(Delogu et al., 2001b). Although mitochondrial dysfunction in this setting may 
increase the risks of infective complications (Delogu et al., 2001b), the 
contribution of various confounding factors such as fasting, insulin resistance 
(Ritz and Berrut, 2005) and anaesthesia (Miro et al., 1999) to this impairment in 
function was, unfortunately, not studied. 
 
1.4.6 Effects of carbohydrate loading on mitochondrial function 
The effects of preoperative conditioning using carbohydrate-based drinks on 
mitochondrial function have not been studied. Hayakawa et al. (Hayakawa et al., 
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2000) examined the effects of intraoperative glucose infusions on hepatic 
mitochondrial energy status (redox state) in 26 patients undergoing elective total 
gastrectomy for cancer. Although their study was weakened because the control 
group also received intraoperative glucose infusion and the authors used an 
indirect measure of hepatic mitochondrial energy status (the arterial ketone 
body ratio), they appeared to show that low mitochondrial energy status 
accompanied preoperative fasting and that this may be improved with 
intraoperative glucose infusion. Animal (Briet and Jeejeebhoy, 2001) and human 
(Briet et al., 2003; Briet et al., 2004) studies on the effects of energy deprivation 
and malnutrition on MMC activity have demonstrated that short-term refeeding 
(1 day in rats, 7 days in humans) restored mitochondrial activity. Although a 7-
day period of refeeding increased human PBMC MMC I activity (Briet et al., 
2003a), normal levels were only attained after one month of refeeding (Briet et 
al., 2004). The heterogeneity of conditions causing malnutrition in these studies 
make it difficult, however, to derive any conclusions regarding the possible 
protective effects of preoperative carbohydrate loading in healthy patients 
undergoing elective surgery. 
 
1.5 Conclusions 
The mechanisms that underlie the development of perioperative insulin 
resistance during fasting and its attenuation by preoperative carbohydrate drinks 
are yet to be defined. Animal studies have shown that energy deprivation has 
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adverse effects on mitochondrial function by decreasing mitochondrial ATP 
synthesis capacity and complex activity, and increasing oxidative injury. 
Furthermore, evidence from human studies suggests that the development of 
insulin resistance during fasting may be linked to impaired mitochondrial 
function. Future studies should investigate whether mitochondrial dysfunction 
underlies the development of insulin resistance in healthy patients undergoing 
elective surgery. 
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Chapter 2 
Hypotheses 
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As previously discussed, the cellular mechanisms underlying the development 
and attenuation of insulin resistance following short-term fasting and 
preoperative conditioning with carbohydrate-based drinks, respectively, are yet 
to be defined. The forthcoming studies hypothesised that: 
A) Short-term fasting (up to 24 hours) fasting would deplete glycogen 
reserves, impair mitochondrial function and alter the expression of key 
metabolic genes and proteins (PDK4, FOXO1, Mt-1A) involved in the 
pathways leading to the development of insulin resistance;   
B) Preoperative ingestion of a carbohydrate-based drink [Oral Nutritional 
Supplement (ONS), Fresenius Kabi, Germany), that also contained 
glutamine and antioxidants, designed to improve perioperative metabolic 
function, would reverse the aforementioned deleterious effects of short-
term fasting.  
 
The rationale underlying the drink (ONS) containing glutamine and antioxidants, 
in addition to carbohydrate, was that these ingredients may provide benefits in 
addition to those provided by carbohydrate loading alone (Houdijk et al., 1998; 
Jones et al., 1999; Baines and Shenkin, 2002; Henriksen et al., 2003; Bakalar et 
al., 2006; Dechelotte et al., 2006). It was hypothesised that: 
C) Preoperative ingestion of ONS would be safe and well tolerated in 
patients undergoing laparoscopic cholecystectomy; 
D) The additional constituents (glutamine and antioxidants) would be 
absorbed and lead to increased perioperative plasma concentrations. 
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A previous study of healthy volunteers (Lobo et al., 2009, vide infra) has 
demonstrated markedly differing gastric emptying times following ingestion of 
ONS and a preoperative clear carbohydrate drink (preOp®, Nutricia Clinical Care, 
UK). Whilst the mean (95% CI) T100 of 400 ml of preOp® was 94 (79-110) min, 
that of the same volume of ONS was 156 (138-173) min. It was hypothesised 
that: 
E) Ingestion of preOp® and ONS would lead to differing postprandial 
metabolic (glucose, NEFA, OHB and glutamine) and hormonal (insulin and 
glucagon) responses.  
 
Finally, glutamine supplementation of preoperative carbohydrate-based drinks is 
thought to delay gastric emptying, as a result of increased glucagon-like peptide 
1 (GLP-1) release, the latter an incretin previously shown to delay gastric 
emptying (Reimann et al., 2004; Karamanlis et al., 2007; Greenfield et al., 2009). 
Furthermore, the addition of lipid to liquid carbohydrate meals is thought to 
result in delayed gastric emptying (Houghton et al., 1990) and blunted 
postprandial glucose and insulin responses (Welch et al., 1987). It was 
hypothesised that: 
F) The gastric emptying times of the preoperative carbohydrate drink 
(preOp®) would be increased by the addition of either glutamine or lipid, 
the lipid based drink being utilised as a positive control for a drink that 
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results in delayed gastric emptying, these effects a consequence of 
differing GLP-1 responses.  
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Chapter 3 
Common methods 
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3.1 Approvals from regulatory bodies 
Ethical approval for these studies was obtained from the University of 
Nottingham Medical School Research Ethics Committee (studies in Chapters 4 
and 6), the Nottingham Research Ethics Committee 1 (study in Chapter 5) and 
the Leicestershire, Northamptonshire and Rutland Research Ethics Committee 2 
(study in Chapter 7). The respective approval numbers for these studies were as 
follows: Chapter 4 (C/12/2007), Chapter 5 (08/H0403/18), Chapter 6 (B/12/2008) 
and Chapter 7 (09/H0402/73). Additional approval for the administration of 
radioactive substances was obtained from the Administration of Radioactive 
Substances Advisory Committee of the UK Department of Health (253/2416/24 
345) for the study in Chapter 7. The respective Research and Development 
approval numbers for the studies in Chapters 4, 5, 6 and 7 were 07GA011, 
07GA010, 09GA001 and 09GA002. The studies in Chapters 5, 6 and 7 were 
registered at clinicaltrials.gov (NCT00662376, NCT00909701, NCT00943020). All 
studies were performed in accordance with the Declaration of Helsinki of the 
World Medical Association. 
 
3.2 Eligibility and exclusion criteria for healthy volunteer studies (Chapters 4, 6 
and 7) 
In the studies detailed in Chapters 4, 6 and 7 healthy male Caucasian volunteers 
(aged 18-45 yrs) with a BMI of 20-25 kg/m2 and no history of abdominal surgery 
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or gastrointestinal disorders were studied. Subjects were excluded if they 
smoked or had a family/personal history of diabetes mellitus or other metabolic 
disorders. 
 
3.3 Randomisation and blinding 
In these studies the computer-generated randomisation codes were performed. 
Allocations were concealed in sequentially numbered sealed opaque envelopes 
and were opened before each arm of the study by a person not involved with the 
study. All study personnel and participants were blinded to treatment 
assignments. The randomisation codes were revealed once data collection, 
laboratory and statistical analyses were complete. 
 
3.4 Collection of blood samples 
Blood was sampled either by venepuncture or via a 19 G venous cannula 
(Venflon®, Ohmeda, Sweden) into the appropriate Vacutainer® blood collection 
tube (Becton Dickinson & Co, UK). In the studies detailed in Chapters 6 and 7, 
arterialised venous blood was sampled by the heated-hand technique as 
previously described (Brooks et al., 1989). In brief, a retrograde venous cannula 
was sited into the dorsum of the hand which was placed into a hand warmer 
(55°C) for at least 15 min prior to each blood sampling time point. As was 
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standard practice in our laboratory, we did not measure the temperature of the 
heated hand placed inside the hot-box.  
 
3.5 Analysis of blood samples 
All assays were performed by trained laboratory staff using standard operating 
procedures and calibrated equipment. The following assays were performed by 
staff at the HPLC laboratory of the Metabolic Physiology Group, School of 
Biomedical Sciences, University of Nottingham: insulin, glucagon, NEFA (Chapters 
5 & 6), β-hydroxybutyrate (OHB, Chapter 6) and glucagon-like peptide 1 (GLP-1). 
The following assays were performed by laboratory staff at the Department of 
Pathology, Nottingham University Hospitals NHS Trust: full blood count (FBC), 
clotting profile, urea and electrolytes (U&E), C-reactive protein (CRP), liver 
enzymes, lipid profile, NEFA (Chapter 4), OHB (Chapter 4) and glucose (Chapters 
4 and 5).  
Measurements of plasma concentrations of vitamin A, C, E, selenium, zinc and 
plasma amino acids were performed by laboratory staff at the Institut für 
Ernährungs- und Lebensmittelwissenschaften, University of Bonn, Germany.  
In the studies described in Chapters 6 and 7 blood glucose was measured using 
the HemoCue® glucose analyzer (HemoCue Ltd., Ängelholm, Sweden).  
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3.5.1 Insulin assays 
Serum insulin was measured using a solid-phase 125I radioimmunoassay (Coat-a-
count insulin kit, Siemens Medical Solutions Diagnostics, Camberley, UK). The 
interassay coefficient of variation for this assay was 6.3%.  
 
3.5.2 Glucagon assays 
Blood samples for glucagon were treated with aprotinin (500 KIU/ml blood, 
Bayer HealthCare, Morristown, NJ, USA) and stored in glass tubes at -80°C until 
analysis. Total pancreatic glucagon concentrations were determined using solid-
phase 125I radioimmunoassays (Double Antibody Glucagon kit, Siemens Medical 
Solutions Diagnostics, Camberley, UK). The interassay coefficient of variation for 
this assay was 4.4%.  
 
3.5.3 Nonesterified/free fatty acid assays 
Serum NEFA/FFA were measured using an automated immunoassay analyser 
(Olympus AU5400) and a commercially available kit (Randox® kit NEFA RB1007, 
County Antrim, UK). The interassay coefficient of variation for this assay was 
3.5%.  
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3.5.4 β-hydroxybutyrate assays 
Serum OHB were measured using an automated immunoassay analyser 
(Olympus AU5400) and a commercially available kit (Randox® kit OHBUT FA115, 
County Antrim, UK). The interassay coefficient of variation for this assay was 
3.5%. 
 
3.5.5 Glucagon-like peptide 1 assay 
Blood (2 ml) for GLP-1 was collected into ice-cooled EDTA tubes and immediately 
treated with 20µl dipeptidyl peptidase IV inhibitor (Millipore, Watford, London, 
UK). After centrifuging at 2000 x g for 10 min (4°C) plasma was collected and 
frozen at -80°C until analysis. GLP-1 concentrations were determined using a 
commercially available kit (GLP-1 [Active] RIA Kit, Linco Research, St. Charles, 
Missouri, USA). The interassay coefficient of variation for this assay was 4.5%. 
 
3.5.6 Vitamin assays 
Plasma vitamin concentrations were determined by high performance liquid 
chromatography (HPLC) as previously described {Erhardt, 1999 #572;Furst, 1990 
#463}. 
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3.5.7 Trace element assays 
Trace element concentrations were determined by atomic absorption 
spectroscopy. 
 
3.5.8 Amino acid assays 
Plasma amino acid concentrations were determined by reversed phase HPLC as 
previously described (Furst et al., 1990).  The interassay coefficient of variation 
for the glutamine assay was 3.7%. 
 
3.6 Protein concentrations 
Protein concentrations were determined in the mitochondrial and enzyme 
suspensions using the Bradford dye-binding (Bio-Rad) protein assay (Bradford, 
1976). This colorimetric assay involves the addition of an acidic dye (Coomassie® 
Brilliant Blue G-250) to protein solution and subsequent measurement at 595 nm 
with a plate reader (Molecular Devices SpectraMaxi 190). Ten dilutions (1 to 10 
µg/ml) of Bovine Serum Albumin (0.01% BSA) protein standards were prepared 
in Eppendorf microtubes. Samples for protein measurement were diluted x 10 
with distilled water. 400 µl of each standard and sample solution (the latter in 
duplicate) were pipetted into a microtube to which was added 100 µl of dye 
reagent concentrate followed by a brief vortex. Samples were incubated at room 
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temperature for at least 5 min, followed by transfer of 200 µl from each 
microtube mix to a microtitre plate for measuring absorbance.  
 
3.7 Composition of study drinks 
The constituents and physical properties of the study drinks [Nutricia preOp® 
(Nutricia Clinical Care, UK) and Oral Nutritional Supplement (ONS, Fresenius Kabi, 
Germany)] investigated in studies outlined in Chapters 5, 6 and 7 are listed in 
Table 3.1 below: 
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Table 3.1: Constituents and physical properties of the study drinks used in 
studies outlined in Chapters 4 and 6. 
 
Nutricia preOp® 
ONS (70 g powder 
reconstituted with water to 
a total volume of 400 ml) 
Volume 400 ml 400 ml 
Carbohydrate 
      
50.4 g 
Maltodextrin + 
fructose 
50 g 
Maltodextrin + saccharose + 
modified starch + gum 
arabic 
Glutamine - 15 g 
Vitamin C - 750 mg 
Vitamin E - 250 mg 
Green tea extract - 1 g 
β-carotene - 5 mg 
Zinc - 10 mg 
Selenium - 150 ʅg 
Fat - 0.218 g 
Energy 200 kcal (836 kJ) 234 kcal (978 kJ) 
Dry matter content 11.3% 16.3% 
pH 4.9 3.9 
Density 1.05 g/l 1.06 g/l 
Osmolarity 228 mOsm/kg 508 mOsm/kg 
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In the randomised double-blind studies described in this thesis, the study drinks 
were reconstituted (ONS) or prepared (preOp®) by a person not involved in the 
studies and served to the study subjects in identical opaque bottles.  
 
3.8 Statistical analyses 
Statistical analysis was performed with SPSS® for Windows v16 software (SPSS 
Inc, Chicago, IL, USA). The Shapiro-Wilkes test was used to determine normality 
of distribution. Data are presented as mean (SE or 95% CI) or median (IQR) as 
appropriate. The paired and independent samples t-tests were used for 
parametric paired and unpaired data, respectively. The Wilcoxon signed rank and 
Mann-Whitney U tests were used for non-parametrically distributed paired and 
unpaired data, respectively. The Chi square test was used for categorical data. 
Comparisons between the study time points for parametric and non-parametric 
data were made using the repeated measures (one-way, two-way or three-way 
as appropriate) ANOVA or the Kruskal Wallis tests, respectively. The appropriate 
post-hoc test (paired t-test or Wilcoxon signed rank test) was used to locate any 
differences. Two-tailed P-values, unadjusted for multiple testing, are reported 
and differences were considered significant at P<0.050. 
 
 
75 
3.9 Funding for studies 
The studies in this thesis were supported by the following grants: 
The Royal College of Surgeons of England one-year research fellowship 
(supported by the Doris Mary Sheppard Legacy and Rosetrees Trust), the Mason 
Medical Research Foundation and the Enhanced Recovery After Surgery Group 
(via an unrestricted educational grant from Fresenius Kabi). The funders of these 
studies had no role in the design and execution of the studies, data analysis, 
writing or decision to submit the manuscripts for publication. 
 
76 
 
 
 
 
 
 
 
 
 
 
Chapter 4 
 
The effects of fasting and refeeding with a metabolic 
preconditioning drink on substrate reserves and 
mononuclear cell mitochondrial function 
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Magnetic resonance spectroscopy (MRS) allows the in vivo assessment of 
glycogen and lipid levels using naturally abundant 13C and 1H nuclei, thereby 
enabling studies of energy metabolism (Morris et al., 1994; Krssak et al., 2000).  
 
4.1 Aims 
The aims of this study were two-fold:  
A) To study the dynamic changes in substrate metabolism and reserves following 
short-term fasting (24 hours) and refeeding with ONS, and  
B) To determine whether mononuclear cell mitochondrial function is altered by 
this period of fasting/refeeding. 
 
4.2 Methods 
4.2.1 Interventions 
After recruitment volunteers completed a 3-day food diary which was used to 
standardise the meal given at the commencement of the study. Volunteers 
abstained from alcohol and caffeine for 24 hours, and from strenuous exercise 
for 3 days prior to the study. Throughout the study the volunteers were asked to 
rest, drink water ad libitum, and were transported to the study sites by taxi to 
eliminate the possible confounding effect of exercise. 
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4.2.2 Standardised meal and ONS 
The aim of the standardised mixed-meal was to load liver and muscle glycogen 
reserves thus representing the baseline fed state. Microdiet® (Downlee 
Systems Ltd., Highpeak, UK) software was used to alter the quantities of the 
meal constituents to provide 40% of the volunteers daily energy intake with a 
macronutrient energy contribution of 50% from carbohydrate, 35% from fat and 
15% from protein. Volunteers consumed the meal within 15 min and time 0 was 
defined as the end of the meal. Two servings of the study drink (ONS) were 
reconstituted from powdered form into a suspension (400 ml) using bottled 
water.  
 
4.2.3 Study protocol 
Volunteers reported for the study at 0745 hours after a 12-hour fast. Height, 
weight and body mass index (BMI) were recorded and the fast commenced after 
ingestion of the standard meal (Figure 4.1).  
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Figure 4.1: Experimental protocol. The baseline fed state was studied 4 hours after 
ingestion of a standardized mixed-meal. At 4, 12, and 24 hours venepuncture was 
performed and magnetic resonance spectroscopy (MRS) performed. Subjects ingested 
the study drink (ONS) at 26 hours following which venepuncture and MRS were 
repeated at 2 and 6 hours postprandially. 
 
 
After 4 hours blood was sampled by venepuncture and MRS scans were 
performed to study the subjects in the baseline fed state. The 4-hour time point 
was chosen given that the mean (95% CI) T100 gastric emptying time of ONS was 
156 (138-174) min (Lobo et al., 2009) and that previous studies have 
demonstrated maximal postprandial increases in liver glycogen within 4-6 hours 
of ingestion of a mixed-meal (Taylor et al., 1996; Carey et al., 2003). Blood 
sampling and MRS scanning were repeated after 12 hours of fasting following 
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which the volunteers were allowed home with instructions to remain fasted. 
Blood sampling and MRS scanning were repeated after 24 hours of fasting had 
elapsed. Volunteers then ingested ONS (within 5 min) following which blood 
samples were obtained and MRS scans performed at 2 and 6 hours 
postprandially. The aforementioned measurements were selected to allow a 
fuller study of the in vivo metabolic changes following fasting and refeeding. 
 
4.2.4 Magnetic resonance techniques 
Nuclear magnetic resonance (NMR) has been widely applied to metabolic studies 
in vivo. It relies on the magnetic properties of nuclei which have a net spin by 
virtue of the spins of their constituent protons and neutrons (Morris et al., 1994). 
NMR involves the interaction of nuclear spins with a static magnetic field and has 
the unique ability to differentiate between different metabolites due to 
chemical shift. The resonance frequency of the signal produced is distinct for 
nuclei in different chemical environments, enabling individual structures to be 
distinguished. The strength of the NMR signal (the area under a peak in the NMR 
spectrum) is proportional to the number of spins contributing to it (Morris et al., 
1994). The wide chemical shift range (>200 ppm) of the 13C nucleus permits 
metabolites to be identified directly and unambiguously from their 13C NMR 
spectra (Morris et al., 1994). The low natural abundance (1.1%) of the stable 
isotope 13C means that only metabolites such as glycogen, that is highly 
concentrated in tissues such as liver and muscle, can be directly observed at 
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natural abundance in vivo (Alger et al., 1981). Despite the ubiquitous presence of 
the proton, the development of high-field instrumentation and water 
suppression techniques has permitted the widespread use of 1H NMR in the 
study of lipid metabolism (Morris et al., 1994).  
MRS was performed on a Philips 3T system at the Sir Peter Mansfield Magnetic 
Resonance Centre, School of Physics and Astronomy, University Campus. The 
MRS scans were performed by the following collaborators: Miss Mary 
Stephenson (PhD student, School of Physics and Astronomy), Miss Elisa Placidi 
(PhD student, School of Physics and Astronomy) and Dr. Luca Marciani (Senior 
RCUK Academic Fellow, Nottingham Digestive Diseases Centre NIHR Biomedical 
Research Unit). A transmit/receive body coil was used for 1H imaging and MRS 
for measurements of liver volume and hepatic and skeletal muscle (soleus) lipid 
concentrations, respectively. A 14 cm 13C surface probe with quadrature proton 
decouple coils was used for measurement of hepatic and calf (gastrocnemius) 
muscle glycogen. We studied the gastrocnemius muscle, in line with previous 
investigators (Carey et al., 2003), as the positioning and aligning of the lower leg 
and calf on the 13C coil was easier and more reproducible than placing the coil on 
top of the thigh quadriceps muscle. Liver volumes were measured using T1-
weighted, breath-hold turbo field echo scan with resolution 2×2×7 mm3, 36 
slices, matrix 180×182, TR = 3.11ms, total scan time 14.4s. The images were 
analysed by drawing regions of interest in Analyze6 (Biomedical Imaging 
Resources, Rochester, MN) and values are reported as volume (litres) and % 
change from baseline. The coefficient of variation (CV) for repeated 
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measurement of liver volume was 0.8%. Hepatic 1H spectra were acquired from a 
30×30×30 mm voxel positioned in the right lobe using a respiratory triggered 
PRESS sequence and the following parameters: echo/repetition time 40/5000 
ms, 16 averages, bandwidth 2000 Hz, 1024 samples. Two 1H spectra were 
acquired in muscle: water-suppressed for intramyocellular lipid (IMCL, 32 
averages) and non water-suppressed for total calf lipid (16 averages). PRESS 
localization was used with echo/repetition time 40/7000 ms, voxel 30x30x50 
mm, bandwidth 2000 Hz, 1024 samples. 1H non water-suppressed spectra were 
post-processed using jMRUI and peak areas were calculated using in-house 
software built in Matlab®. Water suppressed spectra were analysed using the 
AMARES algorithm (Vanhamme et al., 1997) in jMRUI, fitting to Gaussian 
lineshapes. Lipid values are reported as % change from baseline. The CV for 
repeated measurements of liver lipid, IMCL and extramyocellular lipid (EMCL) 
concentrations were 4%, 6% and 21%, respectively. The EMCL CV was higher 
than that for IMCL as the content of extramyocellular lipid is more variable and 
more dependent on the positioning of the voxel. 13C spectra (Figure 4.2) were 
acquired using a proton-decoupled pulse acquire sequence with bandwidth 
7000Hz, 512 samples, 13C adiabatic pulses and narrowband decoupling (3 spectra 
with repetition time 2150 ms, 288 averages, total duration 30 min for the liver 
and 2 spectra with repetition time 1300 ms, 336 averages, duration 15 min for 
the calf). jMRUI was used for post-processing and peak areas were determined 
using in-house software built in Matlab®. Spectral peaks were selected using the 
AMARES algorithm and were fitted to Lorentzian lineshapes. The integral of the 
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glycogen peak was expressed as a fraction of the formate peak derived from a 
phantom containing formate placed at the centre of the 13C coil. Quantification 
of glycogen concentrations was performed using a phantom replacement 
method (Leverton, 2009). In brief, a cylindrical phantom containing a known 
glycogen concentration was placed at various distances from the coil and images 
and spectra were acquired for each position. The images were used to identify 
pixels corresponding to the phantom and those corresponding to the marker at 
the centre of the coil. These were then used to find a relationship between the 
distance between glycogen containing pixels, the coil and the size of the 
resulting glycogen signal. The same was performed for the in vivo images thus 
producing scaling factors for the subjects and phantoms which were used for 
quantification. The subject glycogen concentrations were calculated using the 
following equation: 
 
   Sglycogen/Sformate 
[Subject]=  
   Pglycogen/Pformate 
      scalesubject 
  [Phantom] scalephantom 
 
Where  
[Subject] = the glycogen concentration in the subject,  
[Phantom] = the glycogen concentration in the phantom,  
Sglygogen = the integral of the NMR peak from the subject due to glycogen, 
Sformate = the integral of the NMR peak from the subject due to formate marker, 
Pglycogen = the integral of the NMR peak from the phantom due to glycogen, 
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Pformate = the integral of the NMR peak from the phantom due to formate marker, 
Scalesubject = scaling factor for the subject, 
Scalephantom = scaling factor for the phantom. 
 
 
 
Figure 4.2: Example of the dynamic changes in 
13
C (used to calculate glycogen 
concentrations), during the course of the study, as determined by magnetic 
resonance spectroscopy. Baseline scan was performed 4 hours after the 
standardised mixed-meal. The subsequent scans were performed after 12 and 24 hours 
of fasting (decreased area under 13C peak) and 2 hours following ingestion of the 
carbohydrate-based study drink (ONS). 
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Liver glycogen is reported in mmol and as % change from baseline. Muscle 
glycogen is reported as % change from baseline. The CV for repeated 
measurements of liver and muscle glycogen were 14% and 11% respectively. 
Magnetic resonance spectra were blinded prior to analysis to avoid operator 
bias. 
 
4.1.5 Sampling of blood samples 
The following analyses were performed on blood sampled at the baseline fed 
state, following 12 and 24 hours of fasting and 4 hours after ONS ingestion: FBC, 
U&E, liver enzymes, glucose, insulin, NEFA, OHB, CRP, clotting and lipid profiles. 
Additional blood samples were taken at 2 and 6 hours following ONS intake for 
analysis of blood glucose, insulin, NEFA and OHB concentrations to allow more 
detailed study of changes in intermediary metabolism.  
 
4.2.6 Preparation of mononuclear cells 
Mononuclear cells (MNC) were isolated from 20 ml of venous blood by density 
gradient centrifugation (Boyum, 1968) and following the Histopaque®-1077 
(Sigma-Aldrich, Dorset, UK) manufacturers guidelines (Procedure No. 1077). 
Blood was collected into BD® heparin vacutainers following which it was diluted 
volume for volume with pre-prepared phosphate buffered saline (PBS) solution [I 
PBS tablet dissolved in 100 ml distilled water, then sterilised and filtered using a 
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vacuum driven disposable filtration system (Stericup®, Millipore Ltd., Watford, 
UK) into a 50 ml centrifuge tube (Greiner Bio-One GmbH, Frickenhausen, 
Germany)] and mixed by gentle agitation. Seven ml of Histopaque®-1077 
(Sigma-Aldrich, Dorset, UK) were aliquoted into 15 ml centrifuge tubes. An 
equivalent volume of diluted blood (7 ml) was gently layered onto the 
Histopaque® by tilting the 15 ml centrifuge tube to 45° (Figure 4.3). 
 
 
Figure 4.3: Appearance of peripheral blood layered onto Histopaque® in 5 ml 
centrifuge tubes. 
 
The centrifuge tubes containing the blood/Histopaque® mixture were 
centrifuged (MSE Harrier 15/80) at 400 x g for 30 min at room temperature. The 
centrifuge tubes were carefully removed taking care not to agitate the buffy coat 
(Figure 4.4).  
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Figure 4.4: Appearance of the buffy coat (arrows) following centrifugation of 
blood layered onto Histopaque® at 400 x g for 30 min at room temperature.  
 
 
The excess plasma was removed from each centrifuge tube to within 5 mm 
above the buffy coat and discarded. A 10 ml serological pipette (Greiner Bio-One, 
GmbH, Frickenhausen, Germany) was used to aspirate the buffy coat of 
mononuclear cells (MNC) and decant into a new 50 ml centrifuge tube. RPMI-
1640 (Sigma, Dorset, UK) was added to the MNC to make up to a total volume of 
50 ml and mixed by gentle agitation. The 50 ml centrifuge tube was centrifuged 
(Eppendorf 5702R) at 250 x g for 10 min at room temperature. The centrifuge 
tube was carefully removed ensuring that the resultant pellet of MNC is not 
agitated. The supernatant was discarded leaving the MNC pellet at the base of 
the centrifuge tube (Figure 4.5). 
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Figure 4.5: Appearance of the MNC pellet (arrow) following centrifugation at 
250 x g for 10 min at room temperature and removal of the supernatant. 
 
 
The pellet was washed 3 times with RPMI then added to cryovials (Alpha 
Laboratories, Hampshire, UK) containing a cryoprotectant mix (20% fetal bovine 
serum (Sigma, Dorset, UK), 10% dimethyl sulphoxide hybri-max (Sigma, Dorset, 
UK) and RPMI-1640 (Sigma, Dorset, UK) and placed in a cryogenic freezing 
container (Nalgene, Hereford, UK). The inner chamber of the latter was filled 
with HPLC grade Propanol-2 (Fisher Scientific, Loughborough, UK) and placed in a 
-80°C freezer for at least 24 hours to ensure gentle freezing of the MNC. The 
cryovials were then transferred from the cryogenic freezing container into 
standard cryovial storage containers and frozen at -80°C for future analyses. As 
we planned to lyse the MNC pellets, thereby extracting the mitochondrial 
fraction, we did not seek to assess the purity of the isolated MNC.  
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The MNC were later defrosted by agitating in a water bath at 37϶C. Twenty ml of 
RPMI-1640 (Sigma, Dorset, UK) were added and the suspension centrifuged at 
1000 × g for 10 min at room temperature. The resultant pellet was resuspended 
in RPMI and washed 2 further times. The MNC pellet was resuspended in 1 ml of 
phosphate buffered saline (PBS, 20 mmol/L, pH 7.2) and sonicated for 20 s (4 
bursts of 5 s each, with a 30 s break between each burst) on ice to isolate the 
mitochondrial fraction (Martin et al., 1996). Homogenates were centrifuged at 
10 000 × g for 3 min at 4϶C, the supernatant discarded and the resultant 
mitochondrial pellet resuspended in 100 µl of PBS and placed on ice. 
 
4.2.7 Enzyme assays 
4.2.7.1 Protein concentrations 
Protein concentrations of the MNC mitochondrial fraction were determined by 
the Bradford dye-binding (Bio-Rad) assay (section 3.6).  
 
4.2.7.2 Mitochondrial membrane complex activities 
In a previous study (Briet and Jeejeebhoy, 2001), MNC mitochondrial complex 
activity was found to correlate with mitochondrial complex activity in muscle. As 
such, MNC mitochondrial membrane complex (MMC) activities were used as a 
surrogate marker of muscle mitochondrial function. Mononuclear cell MMC 
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activities were measured spectrophotometrically in a plate reader (Molecular 
Devices SpectraMaxi 190) and the kinetic assays performed in duplicate under 
conditions of maximal reaction velocity at an optimal pH and at room 
temperature, as previously described (Wibom et al., 2002). In brief, reagent 
stock solutions were prepared at the appropriate concentrations and frozen in 
batches for future use: KH2PO4 100mM, MgCl2 0.5M, oxidized cytochrome C 
1.38M, reduced cytochrome C 2mM, Rotenone (saturated in ETOH), Coenzyme 
Q1 6mM and 1mM, Succinate 0.5M and DCIP 0.6M. The following reagents were 
freshly prepared on the day of the experiment: potassium cyanide (KCN) 20mM, 
Antimycin A 0.6mg/ml and NADH 7.35mM. All reagents were obtained from 
Sigma (Dorset, UK), Fischer Scientific (Loughborough, UK), Merck (Darmstadt, 
Germany) and Roche Applied Science (Burgress Hill, UK). 
    
NADH:coenzyme Q reductase (complex I) and NADH:cytochrome C reductase 
(complex I + III) activities  
10 µL frozen mitochondrial suspension were added to 590 µL of a probe solution 
(pH 7.2) consisting of KH2PO4 (5mM), MgCl2 (5mM) and bovine serum albumin 
(0.5 g/L) and kept on ice. Within 1 min this was mixed with another 50 µL of the 
same solution supplemented with saponin (7.15 g/L).  
Complex I: 72 µL of probe solution containing mitochondria were incubated for 7 
min in a reaction mixture (pH 7.5) with the following final composition: KH2PO4 
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(50mM), MgCl2 (5mM), bovine serum albumin (5 g/L), KCN (0.20mM), antimycin 
A (1.2 mg/L) and coenzyme Q1 (0.12mM). NADH was added to a final 
concentration of 0.15mM and the decrease in absorbance was monitored at 
340nm for 1 min before and after the addition of rotenone (2 mg/L). The final 
volume was 150 µL. The rotenone-sensitive activity was calculated with the use 
of an extinction coefficient of 6.81 L/mmol/cm. 
Complex I + III: 6 µL of probe solution containing mitochondria were incubated 
for 7 min in a reaction mixture (pH 7.5) with the following final composition: 
KH2PO4 (50mM), MgCl2 (5mM), bovine serum albumin (5 g/L), KCN (0.20mM) and 
oxidized cytochrome C (0.12mM). NADH was added to a final concentration of 
0.15 mM and the increase in absorbance was monitored at 550nm for 1 min 
before and after the addition of rotenone (2 mg/L). The final volume was 125 µL. 
The rotenone-sensitive activity was calculated. 
 
Succinate:cytochrome C reductase (Complex II + III) activities: 
10 µL frozen mitochondrial suspension were incubated at 37°C for 30 min in 100 
µL of a solution (pH 7.2) consisting of KH2PO4 (50mM), succinate (30mM), MgCl2 
(7.5mM) and saponin (0.45 g/L). The blank rate was measured in the reagent (pH 
7.5) consisting of KH2PO4 (50mM), MgCl2 (5mM), bovine serum albumin (5 g/L), 
KCN (0.20mM), succinate (30mM), rotenone (2 mg/L) and oxidized cytochrome C 
(0.12mM). 5 µL of probe solution containing mitochondria were added and the 
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enzyme-catalyzed reduction of cytochrome C was monitored at 550nm for 2 min. 
The final volume was 150 µL.  
 
Cytochrome C oxidase (complex IV) activity: 
10 µL frozen mitochondrial suspension was diluted to a final volume of 100300 
µL (i.e. 100 U/L of citrate synthase) in a probe solution (pH 7.5) containing 
digitonin (1 g/L) and KH2PO4 (50mM). The blank rate was recorded in the reagent 
(pH 7.5) consisting of KH2PO4 (50mM), rotenone (2 mg/L) and reduced 
cytochrome C (0.03mM). 10 µL of the probe solution containing mitochondria 
were added and the enzyme-catalyzed oxidation of cytochrome C was followed 
at 550 nm for 1 min. The final volume was 250 µL. Reduced cytochrome C was 
prepared using ascorbate as previously described (Birch-Machin et al., 1994). 
Citrate synthase (CS) was used as a mitochondrial marker and determined both 
in muscle tissue and in the mitochondrial suspension according to the principles 
previously described (Wibom and Hultman, 1990).  
 
In view of the limited quantity of MNC mitochondria isolated, it was only 
possible to measure the activities of MMC I, II and IV in N = 7, 12 and 11 
volunteers, respectively. The results were expressed as µmol/min/g protein. The 
CV for the activities of complex I, II and IV assays were 10%, 15% and 12%, 
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respectively, similar to those reported by other groups (Martin et al., 1996; Briet 
et al., 2003b). 
 
4.2.8 Statistical analyses 
The required sample size to detect a change of 40% in liver glycogen (the primary 
endpoint) with a power of 90% at the 95% significance level was 12 subjects and 
was estimated based on the results of a previous study (Casey et al., 2000). 
Secondary endpoints included muscle glycogen concentrations, liver and muscle 
lipid concentrations, blood insulin, glucose, NEFA and OHB, and mononuclear cell 
MMC activity. Statistical analyses aimed to examine the effects on substrate 
reserves, substrate concentrations and mitochondrial function of: 1) 12 and 24 
hour periods of fasting; 2) intake of ONS following a 24 hour fast; and 3) time-
related changes following ingestion of ONS. Two-tailed P-values, unadjusted for 
multiple testing, are reported and differences were considered significant at 
P<0.050. 
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4.3 Results 
The median (IQR) age and mean (SE) baseline weight, height and BMI of the 12 
volunteers were 21 (19-28) yrs, 74 (2.8) kg, 1.79 (0.02) m and 23 (0.62) kg/m2 
respectively. All subjects completed the study with no reported side effects.  
 
4.3.1 Standardised meal 
The mean (SE) reported daily energy intake, calculated from the 3-day food 
diaries (Appendix A), was 9.5 (0.5) MJ/day and the energy, carbohydrate, fat and 
protein contents of the standardized meal were 3.8 (0.2) MJ, 119 (6.4) g, 35 (1.9) 
g and 34 (1.8) g, respectively. The mean (95% CI) energy requirement calculated 
from the resting metabolic rate (RMR) assuming a light level of activity (1.5 x 
RMR) was 11305 (10700-11911) kJ/day (Schofield, 1985). The food diaries 
therefore underestimated daily energy requirements by 16% (Appendix A).   
 
4.3.2 Blood assays 
Over the course of the study, the FBC, U&E, liver enzymes, CRP, clotting profile 
and plasma cholesterol concentration were within the laboratory normal range 
(data not shown). Changes in insulin, glucose, triglycerides, NEFA and OHB 
concentrations are shown in Table 4.1.  
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Table 4.1: The effects of fasting and refeeding with the study drink (ONS) on substrate metabolism.  Serum insulin  Data are expressed in 
mlU/L [mean (SE)]. Laboratory normal non-fasting range: 6-25. Plasma glucose, triglycerides and serum NEFA and OHB concentrations  Data are 
expressed in mmol/L [mean (SE)]. Laboratory normal ranges: glucose (fasting): 3.0-6.1; triglycerides (fasting) 0.45-1.81; NEFA (fasting): 0.1-0.9; OHB 
(fasting): 30-300. P<0.001 indicate significant differences between values after 12 hour fast and those at the baseline fed state. ***P<0.001 
indicates significant difference between values after 24 hour fast and those at baseline. P<0.05, P<0.01, P<0.001 indicate significant differences in 
values after 24 hour fast and those after 12 hour fast. §§§P<0.001 indicates significant difference between values 2 hour after ONS and those after 24 
hour fast. $P<0.05, $$P<0.01, $$$P<0.001 indicate significant difference between values 4 hours after ONS and those after 24 hour fast. #P<0.05, 
##
P<0.01 indicate significant differences between values 6 hours after ONS and those after 24 hour fast.  
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Baseline fed 
state (4 hours 
after standard 
meal) 
After 12 hour 
fast 
After 24 hour 
fast 
2 hours after 
study drink 
4 hours after 
study drink 
6 hours after 
study drink 
Serum insulin,  
N = 12 
16.0 (2.3) 1.9 (0.4) 1.3 (0.1)***, 32.0 (3.9)§§§ 4.5 (1.1)$ 1.6 (0.5) 
Plasma glucose,  
N = 12 
4.3 (0.16) 4.5 (0.08) 4.2 (0.09) 6.6 (0.32)§§§ 4.3 (0.21) 4.1 (0.12) 
Plasma 
triglycerides,  
N = 12 
2.03 (0.26) 0.96 (0.10) 1.17 (0.11)***, 0.79 (0.09)§§§ 0.69 (0.07)$$$ 0.94 (0.09)# 
Serum NEFA,  
N = 12 
0.09 (0.01) 0.67 (0.09) 0.62 (0.09)*** 0.08 (0.02)§§§ 0.34 (0.08)$ 0.92 (0.07)## 
Serum OHB,  
N = 12 
35.1 (2.4) 154.4 (26.3) 247.7 (43.3)***, 31.5 (3.3)§§§ 59.4 (19.9)$$ 414.8 (58.5)# 
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4.3.3 Liver volume, glycogen and lipid 
Compared with the baseline fed-state, liver volume decreased following 12 (-
6%) and 24 hours (-11%) of fasting (Table 4.2, Figure 4.6). Refeeding with the 
study drink attenuated any further decline in liver volume. Fasting for 12 and 24 
hours led to a 29% and a 57% decrease in liver glycogen reserves, respectively. 
By 2 hours following ingestion of ONS, liver glycogen reserves had increased by 
47%. Twenty-four hours of fasting also led to a 34% decrease in liver lipid 
concentrations (Figure 4.6), the latter being unaffected by intake of the study 
drink. 
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Table 4.2: The effects of fasting and refeeding with the study drink (ONS) on liver volume and glycogen concentrations. Liver 
volume  Data are expressed in litres [mean (SE)]. Liver glycogen  Data are expressed in mmol [mean (SE)]. P<0.05, P<0.001 indicate 
significant differences between values after 12 hour fast and those at the baseline fed state. ***P<0.001 indicates significant difference 
between values after 24 hour fast and those at baseline. P<0.001 indicate significant differences in values after 24 hour fast and those after 
12 hour fast.  §§P<0.01 indicates significant difference between values 2 hours after ONS and those after 24 hour fast. $P<0.05 indicates 
significant difference between values 6 hours after ONS and those after 24 hour fast.  
 
 
Baseline fed 
state (4 hours 
after standard 
meal) 
After 12 hour 
fast 
After 24 hour fast 
2 hours after 
study drink 
6 hours after 
study drink 
Liver volume,  
N = 12 
1.8 (0.09) 1.7 (0.10)  1.6 (0.09) ***,  1.6 (0.09) 1.5 (0.08) 
Liver glycogen, N = 12 590.1 (60.1) 421.3 (40.4)  255.9 (27.4) ***,  377.2 (49.8) §§ 370.0 (41.6) $ 
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Figure 4.6: The effects of fasting and refeeding with the study drink (ONS) on 
liver volume, glycogen and lipid concentrations (N = 12). Liver volume, glycogen 
and lipid concentrations  Data are expressed as % change from baseline [mean (SE)]. 

P<0.05, P<0.001 indicate significant differences between values after 12 hour fast 
and those at the baseline fed state. ***P<0.001 indicates significant difference between 
values after 24 hour fast and those at baseline. P<0.001 indicate significant 
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differences in values after 24 hour fast and those after 12 hour fast. §P<0.05 indicates 
significant differences between values 2 hours after ONS and those after 24 hour fast. 
#
P<0.05 indicates significant differences between values 6 hours after ONS and those 
after 24 hour fast.  
 
4.3.4 Muscle glycogen and lipid  
There were no differences in calf muscle glycogen or EMCL concentrations over 
the course of the study (data not shown). Compared to baseline, IMCL 
concentrations increased (23%) following 24 hours of fasting (Figure 4.7). 
Figure 4.7: The effects of fasting and refeeding with the study drink (ONS) on 
calf intramyocellular lipid concentrations (N = 12). Data are expressed as % change 
from baseline [mean (SE)]. *P<0.05 indicates significant differences in IMCL 
concentrations after 24 hour fast compared to concentrations at baseline.  
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4.3.5 Mononuclear cell mitochondrial membrane complex activity 
Compared with the baseline fed state, a 24 hour fast decreased MMC I and II 
activities (-75% and -43%, respectively, Table 4.3). Twenty-four hours of fasting 
also decreased MMC I, II and IV activities compared with those seen following a 
12 hour fast (-72%, -49% and -41%, respectively). Mean activities of MMC I, II 
and IV increased 4 hours after ingestion of ONS but this did not reach statistical 
significance. 
 
 
Table 4.3: The effects of fasting and refeeding with the study drink (ONS) on 
mononuclear cell mitochondrial membrane complex activity. Data are expressed 
as µmol/min/g protein [mean (SE)]. *P<0.05, **P<0.01 indicate significant difference in 
MMC activity after 24 hour fast from that at the baseline fed state. P<0.05, P<0.01 
indicate significant difference in MMC activity after 24 hour fast from that seen after 12 
hour fast.  
 
 
Baseline fed 
state 
(4 hours after 
standard meal)
After 12 
hour fast 
After 24 
hour fast 
4 hours after 
study drink 
MMC I activity,  
N = 7 
51.7 (16.3) 45.9 (14.1)
12.8 
(5.0)*, 
29.6 (12.5) 
MMC II activity,  
N = 12 
29.8 (4.4) 33.2 (4.9) 
17.0 (2.4) 
**, 
21.4 (3.3) 
MMC IV activity, 
N = 11 
30.4 (8.1) 37.6 (9.5) 22.2 (5.5) 28.9 (8.0) 
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4.4 Discussion 
This was the first investigation of simultaneous changes in liver and skeletal 
muscle substrate reserves, intermediary concentrations and MNC mitochondrial 
function in healthy humans who were fasted and then refed using a drink 
designed to improve metabolic function perioperatively i.e. metabolic 
preconditioning. A healthy volunteer model was selected and resembled the 
perioperative scenario, when patients are fasted for prolonged periods, in order 
to avoid the possible confounding effects of anaesthesia and surgery.   
This study demonstrated a 29% and 57% decrease in liver glycogen 
concentrations following 12 and 24 hours of fasting, in line with a previous MRS 
study (Rothman et al., 1991). Fasting also led to a diminution in liver lipid 
reserves reflecting decreased lipogenesis. The progressive decline in liver volume 
following fasting was likely to have resulted from the utilisation of glycogen 
reserves, given that glycogen is a hydrophilic molecule that is stored in a 
hydrated form with three times its own weight in water (Frayn, 1999). Other 
reasons may include the utilisation of liver lipid reserves and a decrease in liver 
and portal blood flow following fasting leading to a decreased hepatic blood 
volume (Gaiani et al., 1989). As would be expected, 24 hours of fasting did not 
deplete muscle glycogen reserves; the latter would require prolonged high 
intensity exercise given that the rate of muscle glycogen breakdown is intimately 
linked to the intensity of contraction (Bergstrom and Hultman, 1967). Finally, 
there was a 23% increase in IMCL concentrations following a 24 hour fast. This 
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finding has not previously been demonstrated after such a short period (24 
hours) of fasting and was in accordance with findings from another group who 
demonstrated a 175% increase in IMCL concentrations following a 67 hour fast 
(Johnson et al., 2006). Interestingly, in that study (Johnson et al., 2006) the 
increase in IMCL concentration correlated negatively with insulin sensitivity (r=-
0.63, P<0.01).  
Thorell et al. (Thorell et al., 1996a) previously studied patients undergoing 
elective open cholecystectomy and demonstrated a 65% higher liver glycogen 
concentrations in those allocated to an overnight preoperative glucose infusion 
(5 mg/kg/min) compared with traditional preoperative fasting. In the present 
study, refeeding with ONS led to a 47% increase in liver glycogen concentrations 
by 2 hours. Refeeding also increased plasma insulin concentrations which 
remained elevated for 4 hours after ingestion of the drink. The insulinogenic 
response at 4 hours differed between the standard mixed-meal and ONS and 
may be related to the differing carbohydrate and protein contents of the two 
meals {Floyd, 1966 #509;Nilsson, 1973 #593;Nilsson, 1973 #592;Shively, 1986 
#508}. Refeeding also led to a decrease in NEFA and ketone body concentrations. 
Importantly, the latter effects persisted for only 4 hours following which 
substrate concentrations increased over and above those measured at the fasted 
state. The increases in NEFA and OHB may have occurred as a result of increasing 
lipolysis and ketogenesis (low insulin concentrations) associated with decreased 
NEFA and OHB utilisation (high carbohydrate and low fat oxidation in peripheral 
tissues following carbohydrate loading). 
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Previous studies have reported that postoperative function of MNC 
mitochondria, and thereby the immune responses, were impaired if preceded by 
fasting but these studies were confounded by the effects of anaesthesia and 
surgery (Delogu et al., 2001a; Delogu et al., 2001b). This study has demonstrated 
that increasing the duration of fasting from 12 to 24 hours significantly 
decreased mononuclear cell MMC I (-72%), II (-49%) and IV (-41%) activities. 
Similar findings have been demonstrated in animal and human studies, albeit 
following longer periods (5 days) of low energy feeding (Madapallimattam et al., 
2002; Briet et al., 2004). Generally, the decrease in MMC activity reflects a 
decrease in mitochondrial oxidative phosphorylation capacity, thereby 
decreasing ATP synthesis capacity and resulting in low energy status (Nelson et 
al., 2008). The findings of this study demonstrate that short-term fasting per se 
affects MNC mitochondrial activity adversely, independent of the effects of 
general anaesthesia and the postoperative cytokine response. Future studies 
should investigate whether these effects act to increase the susceptibility to 
postoperative infections.     
Previous investigators have demonstrated a correlation between MMC activity in 
MNC and that in skeletal muscle (Briet and Jeejeebhoy, 2001). Although further 
definitive studies would be needed, the findings from the present study may 
raise the possibility that fasting might induce mitochondrial perturbations in 
muscle. The latter could lead to decreased insulin sensitivity through lipid-
induced insulin resistance (Roden et al., 2001). Impaired muscle mitochondrial 
function coupled with increased delivery of fatty acids from plasma (elevated 
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fasting NEFA concentrations) may lead to the accumulation of IMCL metabolites 
such as fatty acyl CoAs and diacylglycerol (Morino et al., 2006). Such findings 
were noted in young lean insulin-resistant offspring of parents with type 2 
diabetes, where severe defects in insulin-stimulated muscle glucose metabolism 
were associated with an 80% increase in IMCL concentrations and a 30% 
reduction in rates of mitochondrial activity [ATP production] (Petersen et al., 
2004).  
The present study could not demonstrate that refeeding with the carbohydrate-
based drink reversed the decline in MMC activity seen following fasting but the 
time point chosen to measure mononuclear cell MMC activity following 
refeeding may not have been optimal. An increase in MMC activity may have 
occurred before or after this time point. Furthermore, this study did not seek to 
measure the relative changes in insulin sensitivity, given the difficulty in 
performing a hyperinsulinaemic-euglycaemic clamp alongside the MRS scanning 
and blood sampling protocols. It would have been inappropriate to use other 
means of determining insulin sensitivity [such as Homeostatic Model 
Assessment, HOMA (Matthews et al., 1985)] as subjects were in a fed, not 
fasted, state for part of the protocol. 
In summary, the present study has demonstrated that short-term fasting (up to 
24 hours) decreased substrate reserves and affected MNC mitochondrial 
function adversely. Refeeding with a drink suitable for metabolic 
preconditioning partially reversed the changes in liver glycogen.  
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Chapter 5 
Cellular mechanisms underlying the protective effects of 
preoperative feeding: a randomised study investigating 
muscle and liver glycogen concentrations, mitochondrial 
function, gene and protein expression  
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The effects of preoperative fasting and conditioning with carbohydrate-based 
drinks on mitochondrial function and the expression of key metabolic genes and 
proteins involved in the pathways leading to the development of insulin 
resistance has never been studied in humans (Chapter 1).  
 
5.1 Aims 
The aims of this study were to:  
A) Investigate whether the ingestion of ONS was safe and the extent to which 
the additional ingredients (glutamine and antioxidants) were absorbed and 
resulted in altered plasma concentrations,  
B) Investigate the effects of ONS ingestion on liver and muscle glycogen reserves 
and mitochondrial function, and  
C) Study the effects of preoperative fasting and preoperative conditioning with 
carbohydrate-based drinks on the expression of PDK4, FOXO1 and Mt-1A. 
 
5.2 Methods 
5.2.1 Study design 
This randomised, double-blind, placebo-controlled pilot study was set in a 
university hospital. Adult patients aged between 18-80 yrs with a body weight of 
50-120 kg undergoing elective inpatient laparoscopic cholecystectomy for 
uncomplicated gallstone disease were invited to participate in the study 
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between April 2008 and July 2009. Exclusion criteria included: pregnancy, 
breastfeeding, epilepsy, diabetes, gastro-esophageal reflux disease, hiatus 
hernia, inherited metabolic disorders, choledocholithiasis, HIV, the presence of 
severe organ-specific disorders such as liver/kidney insufficiency, acute 
pancreatitis or psychiatric disorders, patients with known/suspected 
drug/alcohol abuse or those thought unlikely to cooperate with the study 
protocol. This was commercial study in part and was monitored by an 
independent monitor appointed by Fresenius Kabi, Germany. 
 
5.2.2 Interventions 
Participants reported to the laboratory at 7:30 pm on the day prior to surgery 
where height and weight were recorded and blood was sampled (Figure 5.2).  
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Figure 5.2: Schedule of study. Note that each serving of the powered ONS drink was 
reconstituted to a total volume of 300 ml. 
 
At 8 pm patients ingested 2 servings (600 ml) of either the study drink (ONS, 50 g 
carbohydrate per 300 ml serving) or placebo (0 g carbohydrate per 300 ml 
serving) and were allowed home with instructions to fast from food and calorie-
containing drinks. Each serving of ONS was delivered in powdered form and was 
reconstituted with bottled water to a volume of 300 ml. The placebo drink 
contained only artificial colorings and flavorings. On the morning of surgery, 
approximately 3 to 4 hours prior to induction of anaesthesia, patients were 
contacted by telephone and instructed to ingest the final serving of the study 
drink (300 ml). This time point was chosen given that the mean (95% CI) T100 
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gastric emptying time of ONS was 156 (138-174) min (Lobo et al., 2009). Patients 
were admitted to hospital at 7 am. After induction of general anaesthesia, blood 
was sampled prior to the commencement of surgery. Muscle biopsies were 
obtained immediately after making a 12 mm skin incision at the site of the 
infraumbilical port. Part of the rectus abdominis muscle was isolated between 2 
suture ligatures and approximately 500 mg of muscle tissue were sampled using 
a scalpel. Muscle tissue was immediately blotted dry, dissected free of adipose 
and connective tissue and snap frozen in liquid nitrogen. After placement of the 
other laparoscopic access ports, liver biopsies (total approximately 250 mg) were 
obtained using a Tru-Cut® biopsy needle (Cardinal Health, Dublin, OH, USA) and 
immediately snap frozen in liquid nitrogen until analysis. Frozen muscle and liver 
samples were subsequently divided in liquid nitrogen into smaller parts for the 
various assays. On the first postoperative day, blood was sampled again and the 
patients were allowed home when deemed appropriate by the medical team. 
 
5.2.3 Randomisation  
The randomisation code was given to a person not involved in the study who 
prepared the study drinks. The drinks were delivered in sealed sequentially 
numbered identical containers according to the allocation sequence. The 
investigators allocated patients an ascending serial number in the order of their 
enrolment, which corresponded to the randomisation number and allocated the 
patient to one of the two treatment groups. 
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5.2.4 Blood samples  
Blood samples included FBC, U&Es, liver enzymes, CRP, glucose, insulin, FFA and 
concentrations of vitamin C, vitamin E, β-carotene, selenium, zinc and free amino 
acids.  
 
5.2.5 Mitochondrial function 
Frozen muscle tissue (15-20 mg) was homogenised for 2 min on ice in 
homogenisation buffer, 50 µl/mg muscle,  (pH 7.2) consisting of KCl (100mM), 
KH2PO4 (50mM), Tris (50mM), MgCl2 (5mM), EDTA (1mM) and ATP (1.8mM) 
using Duall® glass tissue grinders (Anachem Ltd., Luton, UK). Frozen liver tissue 
(5-15 mg) was homogenised in the aforementioned homogenisation buffer at a 
concentration of 150 µl/mg liver. Muscle and liver MMC activities were 
measured spectrophotometrically and the kinetic assays performed in duplicate 
(section 4.2.7.2). Muscle mitochondrial β-hydroxyacyl CoA dehydrogenase (β-
HAD) activity was measured as described previously (Chi et al., 1983). Protein 
concentrations were determined in the mitochondrial and enzyme suspensions 
by the Bradford dye-binding (Bio-Rad) assay (section 3.6).   
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5.2.6 ATP, phosphocreatine (PCr) and glycogen measurements 
After freeze-drying approximately 30 mg of liver and muscle tissue, visible blood 
and connective tissue were removed and the samples powdered. ATP, PCr and 
glycogen concentrations were determined spectrophotometrically using a 
modification of the method of Harris et al {Harris, 1974 #551}.  
 
5.2.7 Muscle glutamine concentrations 
Having arranged a Human Tissue Transfer Agreement (HTTA), muscle samples 
were shipped on dry ice and glutamine concentrations measured by Dr. van Eijk 
(NUTRIM School for Nutrition, Toxicology and Metabolism of the Maastricht 
University Medical Centre, the Netherlands). In brief, muscle samples were 
homogenized using 100 mg of glass pearls (1 mm diameter) and a micro beat 
beater (BioSpec Products, Bartlesville, OK, USA) for 15 s in 5% (w/v) ice-cold 
sulfosalicylic acid. The homogenate was centrifuged for 10 min at 50 000 g and 
glutamine concentrations were determined as previously described (van Eijk et 
al., 1993). 
 
5.2.8 Quantitative RT-PCR 
RNA was extracted from 20-30 mg frozen muscle and 10-20 mg frozen liver 
tissue using TRI Reagent® (Ambion, Huntingdon, UK). First strand cDNA was 
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synthesized from 1 ʅg of total RNA using Murine Moloney Leukaemia Virus 
(MMLV) reverse transcriptase (Promega, Southampton, UK) and random primers 
(Promega). All reactions were performed in the ABI Prism 7000 Sequence 
Detection System (Applied Biosystems, Foster City, CA, USA). Each well contained 
2 ʅl cDNA, 12.5 ʅl Taqman® Gene Expression master mix (Applied Biosystems), 
1.25 ʅl probe and 9.25 ʅl RNase-free water to make a volume of 25 ʅl. Each 
sample was measured in duplicate. The housekeeping gene used was 
hydroxymethylbilane synthase [HMBS] (Crossland et al., 2008). The thermal 
cycling conditions used were 2 min at 50°C, 10 min at 95°C, followed by 40 cycles 
at 95°C for 15 s and 60°C for 1 min. PDK4, FOXO1 and Mt-1A mRNA expression 
was determined. Relative quantification of the genes of interest was measured 
using the 2-ΔΔCt method. The Ct values for the gene of interest were normalized 
with the Ct values of HMBS. The placebo group was used as calibrator with a 
value of 1. 
 
5.2.9 Western blotting
 
Western blotting was performed by Dr Despina Constantin (Metabolic Physiology 
Group, School of Biomedical Sciences, University of Nottingham). An aliquot of 
each wet frozen muscle sample was homogenised in Tris buffer (Tris 50 
mM/EDTA 1 mM pH 7.5) supplemented with protease and phosphatase 
inhibitors (Sigma, Dorset, UK). After homogenisation, each muscle extract was 
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centrifuged for 15 min at 10,000 g. The supernatant was collected and stored at -
80°C. Protein concentrations were measured by the Bradford dye-binding (Bio-
Rad) assay (section 3.6). Protein samples were run on a 4-12 % Bis-Tris 
acrylamide gel (Invitrogen, Paisley, UK) for 2 hours at constant 200 V and 
transferred on a polyvinylidene difluoride membrane (PVDF) overnight at 
constant 100 mA, in ice-cold buffers (4°C). The protein transfer was checked with 
Ponceau S red staining, before blocking the membrane in BSA and Tris buffer 
saline (TBS) for 1 hour at room temperature. Membranes were then probed with 
the primary antibody overnight at 4°C. The antibodies used in this study 
(phosphorylated FOXO [serine256] and total FOXO1) and PDK4 were obtained 
from Cell Signaling Technology (Danvers, MA, USA), and AbCam Inc (Cambridge, 
USA), respectively. The next day, the membranes were washed in TBS-Tween 20, 
incubated with an IRDye 800 labelled secondary anti-rabbit antibody and further 
quantified by using an Odyssey® Infrared Imaging System (LI-COR, Biosciences, 
NE, USA). 
 
5.2.10 Study outcomes 
This pilot study aimed at determining whether the ingestion of ONS preparation 
was associated with the occurrence of drink-related side effects such as 
pulmonary aspiration, nausea, vomiting, flatulence or diarrhoea. Additional 
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measures included: differences between the two groups of patients in plasma 
glutamine, antioxidant, glucose, insulin and FFA concentrations; liver and muscle 
glycogen concentrations and mitochondrial function, muscle glutamine 
concentrations, and finally, liver and muscle PDK4, FOXO1 and Mt-1A mRNA 
expression. 
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5.3 Results 
One hundred and sixteen patients were screened for inclusion into the study of 
whom 40 were randomised into the two groups (Figure 5.3). 
 
Figure 5.3: Trial flow chart. 
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The mean (SE) age and body mass index of the 20 patients (16 female) in the 
placebo group were 48.8 (2.9) years and 28.8 (1.2) kg/m2 respectively. 
Corresponding values for the 20 patients (15 female) in the ONS group were 51.9 
(3.0) years and 29.2 (1.3) kg/m2. These differences were not statistically 
significant. Patients ingested the final serving of the drinks a mean (SE) of 234 
(5.5) min prior to induction of anaesthesia with no differences between the 
groups. All patients ingested the study drinks at the required time and there 
were no drink-related complications such as nausea, vomiting, aspiration, 
hypersensitivity and diarrhea. Muscle and liver biopsies were obtained after a 
median (IQR) of 251 (235-279) and 260 (241-285) min after ingestion of the 
second serving of the study drinks with no differences observed between the 2 
groups. 
 
5.3.1 Metabolic assays 
There were no differences in FBC, U&E, liver enzymes and CRP (data not shown). 
Similarly, there were no differences between intraoperative blood glucose and 
insulin concentrations between the 2 groups (Table 5.1).  
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Table 5.1: Mean (SE) blood glucose, insulin, free fatty acid, glutamine and 
antioxidant concentrations in the ONS and placebo groups. Independent samples 
t test for all comparisons. N = 19 for placebo group FFA.  
 
 
Placebo group 
(N = 20) 
ONS group 
(N = 20) 
P value 
 
Intraoperative plasma glucose 
concentration, mmol/L  
4.86 (0.1) 4.74 (0.1) 0.465 
Intraoperative serum insulin 
concentration, mlU/L  
5.1 (0.94) 5.3 (1.2) 0.665 
Intraoperative plasma FFA 
concentration, mmol/L  
0.81 (0.06) 0.56 (0.04) <0.01 
Intraoperative plasma glutamine 
concentration, ʅmol/L  556 (12) 609 (23) <0.05 
Intraoperative plasma vitamin C 
concentration, ʅmol/L  63 (5) 125 (7) <0.0001 
Intraoperative plasma vitamin A 
concentration, ʅmol/L  1.3 (0.1) 1.7 (0.2) 0.091 
Intraoperative plasma selenium 
concentration, ʅmol/L  71 (3) 83 (3) <0.01 
Day 1 postoperative plasma 
glucose concentration, mmol/L  
5.79 (0.33) 5.77 (0.29) 0.96 
Day 1 postoperative plasma 
glutamine concentration, ʅmol/L  581 (17) 665 (27) <0.05 
Day 1 postoperative plasma 
vitamin C concentration, ʅmol/L  46 (4) 66 (3) <0.001 
Day 1 postoperative plasma 
vitamin A concentration, ʅmol/L  1.1 (0.1) 1.5 (0.1) <0.05 
Day 1 postoperative plasma 
selenium concentration, ʅmol/L  67 (3) 75 (3) <0.05 
 
119 
Intraoperative FFA concentrations were significantly higher in the placebo group 
(Table 5.1) and there was a significant negative correlation with PDK4 mRNA 
(Figure 5.4).  
 
 
 
Figure 5.4: Correlation between plasma FFA concentrations and the fold-
difference in PDK4 mRNA in the ONS group (relative to the placebo group). 
Pearsons correlation was used. N = 18. 
 
 
Ingestion of ONS led to elevated intraoperative concentrations of glutamine, 
vitamin C, vitamin A and selenium (Table 5.1) with elevated concentrations 
persisting into the first postoperative day. 
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4.3.2 Glycogen and muscle glutamine concentrations 
Preoperative ingestion of ONS led to a highly significant 44% increase in liver but 
not muscle glycogen concentrations (Table 5.2). Although mean muscle 
glutamine concentrations tended to be higher in the ONS group, this did not 
reach statistical significance. 
 
Table 5.2: Intraoperative muscle and liver glycogen and muscle glutamine 
concentrations in the ONS and placebo groups. N = 16 in placebo group for 
glutamine concentration due to limited amount of biopsy tissue. Independent samples t-
test for all comparisons. 
 
Placebo group 
(N = 20)

 
ONS group 
(N = 20) 
P value 
Mean (SE) muscle 
glycogen concentration, 
(mmol/kg dry weight) 
263 (15.0) 261 (24.4) 0.963 
Mean (SE) liver glycogen 
concentration, 
(mmol/kg dry weight) 
694 (47.7) 999 (49.3) <0.001 
Logn mean (SE) muscle 
glutamine concentration, 
(mmol/kg wet weight) 
2.44 (0.05) 2.61 (0.07) 0.078 
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5.3.3 Mitochondrial function 
There were no differences in muscle or liver MMC II, II + III, IV or citrate synthase 
activities between the 2 study groups (Table 5.3). Similarly, there were no 
differences in muscle β-HAD activity, ATP and PCr concentrations (Table 5.3).  
 
Table 5.3: Intraoperative muscle and liver MMC activity, muscle β-HAD, ATP 
and phosphocreatine concentrations in the ONS and placebo groups. N = 20 in 
each group for all muscle analyses except β-HAD where N = 20 in placebo group and 18 
in ONS group. N = 19 in each group for all the liver analyses. Independent samples t-test.  
 
  Placebo 
group 
ONS 
group 
P value 
Muscle 
 
Mean (SE) MMC II 
activity, (µmol/min/g 
protein) 
282.6 (26.1) 302.9 (20.9) 0.548 
Mean (SE) MMC II + 
III activity, 
(µmol/min/g protein) 
498.1 (95.3) 615.4 (90.1) 0.377 
Mean (SE) MMC IV 
activity, (µmol/min/g 
protein) 
805.5 (130.0) 1164.9 (240.6) 0.445 
Mean (SE) Citrate 
Synthase activity, 
(µmol/min/g protein) 
838.7 (101.3) 809.4 (107.5) 0.844 
Mean (SE) β-HAD 
activity, (µmol/min/g 
protein) 
22.3 (4.0) 18.3 (3.0) 0.748 
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Mean (SE) ATP 
concentrations, 
(mmol/kg dry muscle) 
17.2 (0.7) 16.2 (0.63) 0.304 
Mean (SE) 
Phosphocreatine 
concentrations, 
(mmol/kg dry muscle) 
91.2 (5.1) 91.6 (4.4) 0.952 
 
Liver 
 
Mean (SE) MMC II 
activity, (mmol/min/g 
protein) 
2.52 (0.14) 2.48 (0.12) 0.826 
Mean (SE) MMC II + 
III activity, 
(mmol/min/g protein) 
1.09 (0.13) 1.02 (0.10) 0.665 
Mean (SE) MMC IV 
activity, (mmol/min/g 
protein) 
0.47 (0.07) 0.41 (0.06) 0.502 
Mean (SE) Citrate 
Synthase activity, 
(mmol/min/g protein) 
0.15 (0.02) 0.16 (0.02) 0.900 
  
 
5.3.4 Gene and protein expression 
Compared with the placebo group, there were significantly lower expressions of 
muscle PDK4 mRNA (4-fold) and protein (44%) in the ONS group (Table 5.4 and 
Figure 5.5). There were no differences in muscle FOXO1 mRNA, phosphorylated-
FOXO1 (FOXO1Ser256) or total FOXO1 protein expression between the study 
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groups (Table 5.4 and Figure 5.5). There was also a significantly lower (1.5-fold) 
muscle antioxidant gene Mt-1A expression in the ONS group (Table 5.4). There 
were no significant differences in liver PDK4, FOXO1 and Mt-1A mRNA 
expression (Table 5.4). 
 
Table 5.4: Fold-differences in intraoperative muscle and liver PDK4, FOXO1 and 
Mt-1A mRNA expression in the ONS group relative to the placebo group.  Due to 
limited amount of biopsy tissue N = 18, 16 and 15 in each group for muscle PDK4, FOXO1 
and Mt-1A, respectively. N = 17 in each group for liver analyses. Significance determined 
using Mann-Whitney U-test.  
 
 Gene 
Mean (SE) fold-differences in mRNA 
expression in ONS group relative to the 
placebo group 
P value 
Muscle 
PDK4 -4.07 (1.2) <0.001 
FOXO1 0.26 (0.6) 0.189 
Mt-1A -1.49 (2.1) <0.001 
Liver 
PDK4 -0.57 (0.5) 0.118 
FOXO1 0.03 (0.4) 0.348 
Mt-1A 0.38 (0.4) 0.394 
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Figure 5.5a: Muscle PDK4 and Forkhead box O (FOXO) 1 (phosphorylated-
FOXO1
ser256
 and total) protein expression in the ONS and the placebo groups. 
*Significantly different from placebo (P<0.05).  
b: Typical Western blots for PDK4, phosphorylated  (FOXO1
Ser256
) and total 
FOXO1 in the ONS and placebo groups. 
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5.4 Discussion 
The results from this study have demonstrated for the first time in patients 
undergoing surgery that: 1) preoperative feeding with a carbohydrate drink that 
also contained glutamine and antioxidants (ONS) was well tolerated and led to 
increased plasma glutamine and antioxidant concentrations, changes that 
persisted into the first postoperative day, 2) preoperative ingestion of ONS 
resulted in lower expression of skeletal muscle PDK4 mRNA and protein, and 3) 
ingestion of ONS was associated with lower metallothionein-1A expression 
indicating decreased cellular oxidative stress. 
The constituents of ONS were absorbed and led to increased plasma glutamine 
and antioxidant concentrations, changes which persisted up to the first 
postoperative day. There was also a tendency towards higher muscle glutamine 
concentrations in the ONS group intraoperatively. Whilst glutamine 
supplementation in critically ill surgical patients has been associated with 
reduced infectious complications, morbidity and improved metabolic control 
(Houdijk et al., 1998; Bakalar et al., 2006; Dechelotte et al., 2006), a recent study 
has suggested that in patients undergoing elective surgery for gastrointestinal 
cancer, glutamine supplementation did not reduce surgical morbidity (Gianotti et 
al., 2009). There is, however, evidence that preoperative conditioning with 
immune enhancing supplements e.g. glutamine and antioxidants may improve 
the immunometabolic host response (Braga et al., 1999; Tepaske et al., 2001; 
Baines and Shenkin, 2002; Gianotti et al., 2002; Henriksen et al., 2003). Ingestion 
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of ONS also led to a 44% increase in liver glycogen concentrations, confirming 
the findings from the magnetic resonance spectroscopy study (Chapter 3). 
However, there was no difference in muscle glycogen concentrations, which was 
not surprising given that this period of fasting without exercise would not have 
depleted muscle glycogen reserves (Bergstrom and Hultman, 1967).  
In the present study a surgical model that induced minimal surgical stress 
(laparoscopic surgery) was selected to evaluate the effects of preoperative 
fasting versus feeding per se, without the confounding effects of major surgery 
(Thorell et al., 1993). Although otherwise healthy patients undergoing 
laparoscopic cholecystectomy may not routinely need preoperative nutritional 
support, preoperative carbohydrate loading may reduce postoperative insulin 
resistance in this group of patients as well (Faria et al., 2009). Muscle and liver 
biopsies were obtained close to the commencement of the operation. At this 
time the placebo group had been fasted for approximately 12-14 hours and both 
study groups had experienced minimal surgical stress (induction of anaesthesia 
and skin incisions associated with minimal access surgery). A previous healthy 
volunteer study demonstrated a 4-fold upregulation in skeletal muscle PDK4 
mRNA expression following 48 hours of starvation, associated with a 42% 
reduction in whole body insulin sensitivity (Tsintzas et al., 2006). These changes 
were independent of the phosphorylation status of the transcription factor 
FOXO1 protein. Accordingly, the present study has demonstrated that even 
following a short period of fasting (15 hours) and minimal operative stress, there 
was a 4-fold lower expression of muscle PDK4 mRNA and 44% lower expression 
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of protein in the ONS group, compared with the placebo group, with no 
differences seen in FOXO1 mRNA or protein expression. These novel findings 
suggest a mechanism by which preoperative feeding with carbohydrate-based 
drinks attenuates the development of insulin resistance which otherwise would 
result from preoperative fasting (Essen et al., 1995; Thorell et al., 1996b; Thorell 
et al., 1999b; Faria et al., 2009). The protective effects of preoperative feeding, 
demonstrated in previous studies (Essen et al., 1995; Thorell et al., 1996b; 
Thorell et al., 1999b; Faria et al., 2009) may, therefore, be secondary to lower 
muscle PDK4 expression, thereby enabling PDC activity and carbohydrate 
oxidation. Although ONS contained glutamine and antioxidants in addition to 
carbohydrate, it is likely that these effects were related, in part, to the 
carbohydrate constituent of the drink given that previous studies have 
demonstrated reversal of starvation-induced changes in PDK4 expression and 
PDC activity following refeeding with a carbohydrate-rich diet (Wu et al., 1999; 
Tsintzas et al., 2006). Previous studies have also examined the roles of insulin, 
FFA and transcription factors such as peroxisome proliferator-activated receptors 
(PPAR) α and δ with a view to understanding the mechanisms involved in 
regulating the PDK4 gene (and therefore PDC activity) (Lee et al., 2004; Kim et 
al., 2006; Tsintzas et al., 2006; Tsintzas et al., 2007; Connaughton et al., 2009). 
Insulin strongly suppressed PDK4 expression in skeletal muscle (Lee et al., 2004; 
Connaughton et al., 2009) but this effect was attenuated by elevated FFA 
concentrations (Kim et al., 2006; Tsintzas et al., 2007). On the basis of animal 
experiments, it has been proposed that elevated FFA mediated the starvation-
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induced upregulation of PDK4 expression via a PPAR-dependent process (Wu et 
al., 1999), however, these findings were contrary to a previous healthy volunteer 
study (Tsintzas et al., 2006) from our laboratory. In the current study, there were 
no differences in intraoperative insulin concentrations between the two groups. 
The restraining effect of insulin on adipose tissue lipolysis persisted for 4 hours 
after ingestion of ONS as evidenced by the lower FFA concentrations in the ONS 
group. Elevated plasma FFA concentrations result in increased fatty acid flux 
through skeletal muscle, the latter a possibly resulting in elevated IMCL 
concentrations (Phillips et al., 1996). Interestingly, PDK4 mRNA expression 
correlated significantly with FFA concentrations (Figure 4.4) providing further 
evidence that elevated FFA concentrations may indeed regulate PDK4 
expression, albeit in a manner distinct from PPAR pathways. There were no 
differences in liver PDK4 and FOXO1 mRNA expression between the two groups, 
providing further evidence that the liver does not play a major role in mediating 
the development of fasting-induced insulin resistance.  
Another novel finding in this study was the 1.5-fold lower expression of Mt-1A 
mRNA in muscle, indicative of a reduction in cellular oxidative stress, in the ONS 
fed group. Increased plasma Mt-1 concentrations have been noted after 
elective surgery (Akintola et al., 1997) and a previous study has demonstrated 
that metallothionein increased mitochondrial inner membrane permeability 
(Simpkins et al., 1998). However, future studies would be needed to study the 
respective contributions of the ingredients of ONS to this finding and the clinical 
implications of lower Mt-1A mRNA expression on mitochondrial function. In this 
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study, no differences were detected in liver and muscle mitochondrial function 
between the two study groups.  
A major limitation of this study was that it is not possible to attribute the 
aforementioned beneficial effects solely to one of the constituents of the drink 
(carbohydrate, glutamine and antioxidants). Further studies would need to 
investigate the contributions of the different constituents of the drink to any 
potential beneficial effects observed. Furthermore, as muscle and liver were 
sampled at the commencement of surgery, changes in gene and protein 
expression demonstrated in the present study are likely to have resulted from 
preoperative fasting as opposed to surgical stress per se.   
In conclusion, the present study has demonstrated that preoperative ingestion of 
a carbohydrate-based drink that contained glutamine and antioxidants was 
associated with lower muscle PDK4 mRNA and protein expression. The 
differences in muscle PDK4 are a mechanism by which preoperative feeding with 
carbohydrate-based drinks attenuates changes in insulin sensitivity that result 
from preoperative fasting. 
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Chapter 6 
A randomised crossover study of the metabolic and 
hormonal responses following ingestion of two 
preoperative conditioning drinks  
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A previous study demonstrated, using magnetic resonance imaging, that the 
gastric emptying of the two drinks (preOp® and ONS) differed significantly in 
healthy volunteers (Lobo et al., 2009). Whilst the mean (95% CI) T100 of 400 ml of 
preOp® was 94 (79-110) min, that of the same volume of ONS was 156 (138-173) 
min. This difference was thought (Lobo et al., 2009) to be due to the presence of 
particulate matter in the ONS suspension and differing nutrient loads of the two 
drinks.  
 
6.1 Aims 
The aims of the present study were to study the postprandial metabolic and 
hormonal responses following ingestion of preOp® and ONS. Understanding 
these responses may help optimise the timing of administration of these drinks 
preoperatively, given that the optimal time of ingestion prior to surgery may not 
necessarily be the time at which the drinks empty from the stomach.  
 
6.2 Methods 
6.2.1 Interventions 
Volunteers abstained from alcohol and caffeine for 24 hours, and from strenuous 
exercise for 3 days prior to the study. The study commenced at 7:30 am 
following an overnight fast. Height and weight were recorded and a retrograde 
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venous cannula sited in the dorsum of the hand to allow sampling of arterialised 
blood. Baseline bloods (vide infra) were sampled, following which the subjects 
were randomised to receive one of the two study drinks. The constituents and 
physical properties of the two study drinks are listed in section 3.7. ONS was 
reconstituted from powdered form (70 g) with water to a volume of 400 ml on 
the morning of the study. Participants ingested the drink within 1 min and time 0 
was defined as the end of the drink. Blood samples were obtained at 20 min 
intervals for 360 min. Subjects attended for the second arm of the study after an 
interval of 5-7 days. 
 
6.2.2 Blood samples 
Blood was sampled for FBC, U&E, liver enzymes, CRP at baseline and for glucose, 
insulin, glucagon, NEFA and glutamine at baseline and every 20 min after 
ingestion of the drinks for 360 min. Blood samples for NEFA were collected into 
chilled tubes containing preservatives to prevent lipolysis elevating NEFA 
concentrations (200 ʅl ethylene glycol tetraacetic acid and glutathione (7.5 ʅl/ml 
blood) and 3 mg/ml tetrahydrolipstatin (5 ʅl/ml blood). Blood samples for β-
hydroxybutyrate (OHB) were collected into a microcentrifuge tube containing 
10% perchloric acid (2µl/µl blood), mixed to allow precipitation and frozen at -
20°C until analysis. Paired samples were selected from 6 volunteers at random 
for measurement of glutamine concentrations.  
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6.2.3 Study outcomes and statistics 
The key outcome measure in this pilot study was differences in postprandial 
glucose concentrations. Other outcomes included differences in postprandial 
concentrations of insulin, glucagon, NEFA and OHB. As this was a pilot study it 
was not possible to perform a sample-size calculation. However, based on the 
results of a previous study (Lobo et al., 2009) N=12 volunteers were considered a 
sufficient number to demonstrate clinically relevant differences between the 2 
drinks. Comparisons between the study time points were made using the two-
way repeated measures ANOVA with the paired t post-hoc test. Two-tailed P-
values, unadjusted for multiple testing, are reported and differences were 
considered significant at P<0.050. 
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6.3 Results 
The mean (SE) age, weight, height and BMI of the 12 volunteers were 21.4 (0.9) 
yrs, 74.4 (1.96) kg, 1.79 (0.02) m and 23.2 (0.48) kg/m2 respectively. All subjects 
completed the study with no reported side effects. There were no differences in 
FBC, U&E, liver enzymes and CRP between the two study arms (data not shown). 
 
6.3.1 Glucose, insulin and glucagon concentrations 
Following ingestion of preOp®, glucose concentrations peaked within 40 min 
(Figure 6.1A) before returning to baseline concentrations at 80 min. In contrast, 
ONS ingestion led to a smaller peak (within 40 min) in glucose concentrations, 
the latter remaining higher than those following preOp® at 100 min. Ingestion of 
preOp® led to significantly higher insulin concentrations (Figure 6.1B) than those 
seen following ONS, with peak concentrations occurring after 40 and 20 min, 
respectively. By 160 min, insulin concentrations had decreased in both groups to 
baseline values seen following an overnight fast. Compared to baseline, glucagon 
concentrations decreased (Figure 6.1C) following ingestion of preOp® with the 
lowest concentrations seen at 120 min. In contrast, this decrease in glucagon 
concentrations was not seen following ingestion of ONS, where concentrations 
remained higher than those in the preOp® arm.  
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Figure 6.1: Blood glucose (A), serum insulin (B) and plasma glucagon (C) concentrations following ingestion of Nutricia preOp® ({) and 
ONS (z). N = 12. Statistical comparison of preOp® vs ONS: *P<0.05, **P<0.01, ***P<0.001.  
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6.3.2 NEFA and OHB concentrations 
Ingestion of both study drinks led to a decrease in serum NEFA and OHB from 
concentrations measured following the overnight fast (Figure 6.2). There was a 
postprandial rebound increase in NEFA and OHB concentrations such that at 360 
min, concentrations were 2- and 3-4-fold higher, respectively, than those seen 
following an overnight fast.   
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Figure 6.2: Serum non-esterified fatty acid (A, N=12) and serum β-hydroxybutyrate (B, N=11) concentrations following ingestion of 
Nutricia preOp® ({) and ONS (z).  
141 
6.3.3 Glutamine concentrations 
As expected, ingestion of preOp® was not associated with a change in plasma 
glutamine concentrations (Figure 6.3). In contrast, ingestion of ONS was 
associated with significantly increased plasma glutamine concentrations that 
remained elevated for 120 min. 
 
 
Figure 6.3: Plasma glutamine concentrations following ingestion of Nutricia 
preOp® ({) and ONS (z). N=6. Statistical comparison of preOp® vs ONS: **P<0.01. 
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6.4 Discussion 
This study, in a healthy volunteer model selected to avoid possible confounding 
effects of anaesthesia and surgery, has demonstrated significant differences in 
the metabolic and hormonal responses following ingestion of two carbohydrate-
based preoperative drinks. 
The peaks in glucose and insulin concentrations were blunted after ingestion of 
ONS when compared with preOp®. Furthermore, ONS ingestion was associated 
with a slower decline in glucose and insulin from their postprandial peaks. Thus, 
ingestion of preOp® was associated with rapid changes, albeit higher 
concentrations, in glucose and insulin, while ONS led to more physiologically 
stable responses with lower postprandial concentrations of glucose and insulin. 
The latter responses may be clinically advantageous in patients with type 2 
diabetes and impaired glucose tolerance, especially as preoperative conditioning 
with carbohydrate-based drinks was shown to be well tolerated in this group 
(Breuer et al., 2006; Gustafsson et al., 2008).  
The differing magnitudes of postprandial glucose and insulin responses may have 
occurred for a number of reasons. Firstly, the GE characteristics of the two drinks 
differed significantly (mean T100 for 400 ml of preOp® was 94 min and for ONS 
156 min (Lobo et al., 2009)) and the rate of GE is one of the determinants of 
postprandial glycaemic responses (Horowitz et al., 1993). The more rapid GE of 
CCD could have led to greater postprandial increases in glucose concentrations 
thereby stimulating greater insulin release. In contrast, absorption of ONS may 
143 
have been delayed by slower GE thereby blunting glucose and insulin 
responses. Secondly, the delay in GE following ONS ingestion may have resulted 
from increased glucagon-like peptide-1 (GLP-1) release from intestinal L cells. 
GLP-1 is an incretin known to delay GE (Greenfield et al., 2009) and a previous 
cell culture study has demonstrated glutamine to be a potent stimulant of GLP-1 
release from GLUTag cells (murine GLP-1-secreting cell line) (Reimann et al., 
2004). Finally, human studies have demonstrated that glutamine 
supplementation increases postprandial and post-exercise insulin-mediated 
glucose disposal without elevating plasma insulin (Borel et al., 1998; Bowtell et 
al., 1999; Iwashita et al., 2005; Iwashita et al., 2006). Increased glucose disposal 
following ONS ingestion could, therefore, have resulted in lower plasma glucose 
concentrations. However, the latter hypothesis requires further study.  
In the present study the glutamine constituent of ONS was absorbed and led to 
increased plasma concentrations. Glutamine was shown to stimulate glucagon 
release (Greenfield et al., 2009), and this may have contributed to higher 
postprandial glucagon concentrations in the ONS arm. Although glucagon 
stimulates hepatic gluconeogenesis, a corresponding increase in plasma glucose 
concentrations was not noted following ONS.  
The present study was limited in that changes in postprandial insulin sensitivity 
and glucose disposal were not measured. However, it was necessary to 
determine the metabolic response following ingestion of these study drinks to 
allow the appropriate timing of hyperinsulinaemic-euglycaemic clamps. 
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Furthermore, the study design did not permit analysis of the effects of differing 
carbohydrates mixtures within the drinks on postprandial glucose and insulin 
responses. However, previous studies have examined the effects of 
maltodextrins and fructose on liver lipogenesis, insulin sensitivity, hepatic insulin 
resistance and GE (Daly et al., 1997; Soop et al., 2004; Basciano et al., 2005). It is 
also of note that the fructose constituent of preOp® may have been converted 
to glucose thereby further increasing postprandial plasma glucose 
concentrations over and above those seen in the ONS arm.  
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Chapter 7  
A randomised crossover study on the effects of glutamine 
and lipid on the gastric emptying time of a preoperative 
carbohydrate drink  
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The mechanisms underlying the differing gastric emptying characteristics of the 
two drinks (ONS and preOp®) and the resultant metabolic effects were unclear, 
but may have been due to the stimulatory effect of amino acids on gastric 
secretion (Oberhelman et al., 1952; Feldman et al., 1978) or due to the increased 
viscosity and density caused by the addition of other nutrients to the 
carbohydrate constituent of the drinks (Marciani et al., 2000). Furthermore, 
glutamine ingestion is thought to release glucagon-like peptide 1 (GLP-1), which 
is an incretin that delays gastric emptying (Reimann et al., 2004; Karamanlis et 
al., 2007; Greenfield et al., 2009). Finally, the addition of lipid to liquid 
carbohydrate meals results in delayed gastric emptying (Houghton et al., 1990) 
and blunted postprandial glucose and insulin responses (Welch et al., 1987).  
 
7.1 Aims 
The aims of this study were, therefore, to investigate whether the addition of 
glutamine or lipid to a carbohydrate-based preoperative conditioning drink, 
whilst maintaining isocaloricity, altered the gastric emptying characteristics and 
resultant postprandial glucose and insulin responses. Understanding these 
differences would allow the optimisation of the formulation and timing of 
administration of such drinks.  
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7.2 Methods 
7.2.1 Interventions 
Participants reported to the laboratory at 7:30 am following an overnight fast 
having abstained from alcohol and caffeine for 24 hours, and from strenuous 
exercise for 3 days prior to the study. Height and weight were recorded and a 
retrograde cannula sited in the dorsum of the hand to allow sampling of 
arterialised venous blood. Baseline bloods (vide infra) were sampled, following 
which radioactive markers (0.25 MBq 99mTc), were attached to the skin anteriorly 
and posteriorly at the lower right costal margin. Subjects were randomised to 
receive one of the three study drinks (Table 7.1, vide infra) which were ingested 
within 1 min, time 0 being defined as the end of the drink. Blood was sampled 
immediately followed by serial anterior and posterior scintigraphic images each 
of 30 sec duration (vide infra), at 20 min intervals for 240 min. Imaging was 
terminated prior to this if the isotope was not detectable in the stomach. 
Subjects attended for the subsequent two arms of the study after intervals of 5-7 
days.  
 
7.2.2 Randomisation  
All study personnel were blinded to treatment assignment. It was not possible to 
fully blind the participants to treatment allocations as the drinks had different 
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textures and tastes. However, the participants were not informed of the 
order/which drink they had consumed.  
 
7.2.3 Study drinks 
Each of the three isocaloric-isovolumetric study drinks (carbohydrate only [CCD]; 
carbohydrate & glutamine [CCD/G], and carbohydrate & lipid [CCD/L], Table 7.1) 
was prepared at room temperature on the morning of the study using the 
appropriate volume of preOp®, to which was added 2.5% weight for weight of 
an emulsifier (Tween 60V Pharma, Croda, Fogars de la Selva, Spain). An 
emulsifier was added to maintain the drinks in suspension and the lipid spatial 
distribution of the CCD/L drink (Marciani et al., 2006). 
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Table 7.1: Constituents and physical properties of the three isocaloric-
isovolumetric study drinks. The carbohydrate component was derived from preOp® 
(Nutricia Clinical Care, Trowbridge, UK), the volume of which was adjusted to ensure an 
equal energy load between the drinks. 
 
 
Carbohydrate 
only [CCD] 
Carbohydrate & 
glutamine [CCD/G] 
Carbohydrate & 
lipid [CCD/L] 
Volume, ml 410 410 410 
Approximate 
calories, kCal 
207 207 207 
Carbohydrate, g 50.4 36 36 
Glutamine, g 0 15 0 
Lipid, g 0 0 7 
Tween 60 
emulsifier, ml 
10 10 10 
Osmolality, 
mOsm/kg 
297 460 207 
 
 
To ensure that the three drinks were isocaloric and isovolumetric to CCD, the 
quantity of carbohydrate in the CCD/G and CCD/L formulations was reduced, and 
the overall caloric content maintained by addition of either 15 g glutamine 
(Adamin-G®, SHS International Ltd., Liverpool, UK) or 7 g lipid (Corn oil, 
Sainsburys, London, UK). The drinks (CCD/G and CCD/L) were subsequently 
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brought to the required total volume (410 ml) using water. The drinks were 
mixed using a blender (Cookworks, Vancouver, BC, Canada) and transferred to 
identical opaque bottles to which was added 5MBq Tc-99m-DTPA was added as a 
non-absorbable tracer. The constituents and physical properties of the study 
drinks are given in Table 7.1. The stability of the drinks, and 99mTc label 
contained therein, were studied in vitro by placing the drinks into 3 adjacent 
compartments of a VanKel 7000 dissolution instrument (VanKel Industries Inc, 
Edison, NJ, USA) maintained at 37°C by a heated water pump (VanKel VK750, 
Edison, NJ, USA). Static imaging (vide infra) of the chambers containing the drinks 
was performed with the gamma camera at 20 min intervals for 100 min (Figure 
7.1A).  
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Figure 7.1A: In vitro dispersion and stability studies of the three study drinks 
(carbohydrate only drink [CCD], carbohydrate & glutamine drink [CCD/G], and 
carbohydrate & lipid drink [CCD/L]). The right chamber contains CCD; middle 
chamber CCD/G; and left chamber CCD/L. Regions of interest were drawn around the 
top, middle and bottom of each chamber to enable calculation of the count rates 
thereby indicating the distribution of the 99mTc label over time in these chambers.  
 
 
Analysis of regions of interest (ROI) drawn over the top, middle and bottom of 
the dissolution chambers demonstrated that the drinks remained stable over 
time with homogenous dispersion of the 99mTc label throughout (Figure 7.1B).  
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Figure 7.1B: Dispersion of the 
99m
Tc label and stability of the drinks over a 100 
min time period. No differences were found in the % change in count rates at the top, 
middle and bottom of the dissolution chambers with the passage of time indicating an 
even distribution of the 99mTc label within the study drinks. 
 
 
To mimic the acidic environment of the stomach, the stability studies were 
repeated following the addition of 30 ml (Brady et al., 2003) of simulated gastric 
fluid [SGF] (Test solutions) to the three drinks, the drinks again remaining stable 
following addition of SGF (Figure 7.1C).  
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Figure 7.1C: Dispersion of the 
99m
Tc label and stability of the drinks over a 100 
min time period following addition of simulated gastric fluid to the study 
drinks. No differences were found in the % change in count rates at the top, middle and 
bottom of the dissolution chambers with the passage of time, indicating an even 
distribution of the 99mTc label within the study drinks. 
 
 
7.2.4 Blood samples and metabolic assays 
Arterialised venous blood was sampled for glucose, insulin, and GLP-1 
concentrations.  
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7.2.5 Scintigraphic acquisitions and analyses 
Scintigraphic data were acquired (by Ms. Elaine Blackshaw, Clinical Trials 
Manager, Department of Physics, Queens Medical Centre, Nottingham) using a 
Mediso Nucline™ X-ring-R gamma camera (Mediso Medical Imaging Systems, 
Budapest, Hungary) fitted with a low energy collimator and peaked at 140 keV 
for 99mTc. The 256 x 256 pixel matrix images were transferred to a Hermes 
dedicated nuclear medicine computer (Nuclear Diagnostics, Gravesend, UK) for 
analysis. ROI were created around the computer-generated image of the 
stomach for both anterior and posterior images and counts were recorded. The 
count rates were corrected for background radiation, radionuclide decay and the 
geometric mean of the anterior and posterior measurements calculated. The 
time-activity curve was expressed as a percentage of the total meal in the 
stomach against time, from which the times for 50% and 90% emptying (T50 and 
T90) were derived from simple interpolation of the data points on the gastric 
emptying curve.  
 
7.2.6 Study outcomes and statistical analyses 
The main outcome of this pilot study was the T90 gastric emptying time following 
ingestion of the study drinks. Secondary outcomes included T50 gastric emptying 
time, blood glucose, insulin and GLP-1 concentrations. As this was a pilot study it 
was not possible to perform a sample size calculation. However, based on the 
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results of a previous study (Lobo et al., 2009), we estimated that ten volunteers 
would be sufficient to detect clinically relevant differences between the three 
drinks. The three-way repeated measures ANOVA was performed with the 
paired t post-hoc test. Two-tailed P-values, unadjusted for multiple testing, are 
reported and differences were considered significant at P<0.050. 
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7.3 Results 
The mean (SE) age, weight, height and BMI of the participants were 29 (2) yrs, 
69.4 (1.3) kg, 1.8 (0.01) m and 22.6 (0.3) kg/m2, respectively. All ten subjects 
approached passed the inclusion criteria (Section 3.2) and agreed to participate 
in the study. All subjects completed the study with no reported side effects.  
 
7.3.1 Gastric emptying times 
There were no significant differences in the T50 gastric emptying times between 
the three study drinks (Figure 7.2). In contrast, the T90 times were shortest for 
the CCD/L, being significantly different from the CCD (Figure 7.2).  
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Figure 7.2: T50 (top) and T90 (bottom) gastric emptying times for the 
carbohydrate only (CCD), carbohydrate & glutamine (CCG/G), and 
carbohydrate & lipid drinks (CCD/L). N = 10. 
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7.3.2 Glucose, insulin and GLP-1 concentrations 
Blood glucose concentrations peaked at 40 min for CCD and CCD/L before 
declining to baseline concentrations at 100 min (Figure 7.3A). Ingestion of the 
CCD/G drink was associated with a blunted glucose response compared to the 
other two drinks, with a lower glucose peak at 40 min [6.2 (0.2) mmol/L]. There 
were no differences between the three drinks in peak insulin concentrations at 
40 min, although there was a slower decline to baseline insulin concentrations 
following ingestion of CCD (Figure 7.3B). Finally, there were no differences in 
postprandial plasma GLP-1 concentrations between the three study drinks 
(Figure 7.3C). 
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161 
C: 
 
Figure 7.3: Blood glucose (A), insulin (B) and glucagon-like peptide 1 (C) concentrations following ingestion of the three study drinks 
(carbohydrate only [CCD], carbohydrate & glutamine [CCD/G], and carbohydrate & lipid [CCD/L]). N = 10. *P<0.05 and **P<0.01 for CCD vs 
CCD/L; P<0.05 and P<0.01 for CCD vs CCD/G; P<0.05 and P<0.01 for CCD/G vs CCD/L.  
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7.4 Discussion 
This study in healthy volunteers has demonstrated that, contrary to current 
literature, the addition of glutamine or lipid to a preoperative carbohydrate 
drink did not result in delayed gastric emptying. Supplementing the 
carbohydrate-drink with glutamine did, however, lead to blunted postprandial 
glucose and insulin responses but these, together with the gastric emptying 
characteristics, did not result from differences in the magnitude of postprandial 
GLP-1 concentrations between the different drinks.  
The methodology in the present study used drinks designed to allow the study of 
the effects on gastric emptying of supplementing a preoperative carbohydrate-
based drink with glutamine, the lipid-containing drink being utilised as a positive 
control for delayed gastric emptying. All three drinks were isocaloric and 
isovolumetric thus eliminating potential confounding effects on gastric emptying 
from these variables (Houghton et al., 1990). The distribution of the isotope 
within the drinks was homogenous over the period of study with no evidence of 
settling or separation of the drinks constituents, as indicated by the stability 
experiments with and without simulated gastric fluid. Only males were included 
in order to eliminate the confounding effects of hormonal changes during the 
menstrual cycle (Lobo et al., 2002; Brennan et al., 2009). Whilst it would have 
been clinically advantageous to undertake the present study in patients 
undergoing surgery, the latter would have precluded a crossover design and 
could have been confounded by differing patient co-morbidities or the ingestion 
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of drugs that altered gastric emptying rates. The volunteers would not have 
experienced preoperative anxiety encountered in clinical practice, however, the 
former was previously shown not to delay gastric emptying rates (Nygren et al., 
1995). Finally, although gastric scintigraphy measures the rate of emptying of the 
isotope from the stomach and is regarded as the gold-standard technique for 
measuring gastric emptying (Collins et al., 1983), it provides little information on 
gastric secretions induced by nutrient ingestion, the latter contributing to total 
gastric volumes which are easier to quantify by magnetic resonance imaging 
(Lobo et al., 2009).  
The CCD had the longest gastric emptying time, the latter likely to have resulted 
from the high carbohydrate content of the drink of the drink (Vist and Maughan, 
1995). The addition of glutamine to preOp® (CCD/G), whilst maintaining 
isocaloricity, markedly increased the osmolality above that of CCD, yet this did 
not delay gastric emptying. It is therefore likely that gastric emptying is more 
dependent on carbohydrate content rather than osmolality per se (Vist and 
Maughan, 1995). The isocaloric CCD/L had the lowest osmolality and, contrary to 
what was expected (Houghton et al., 1990), emptied faster than the other two 
drinks. This may have occurred as a result of the CCD/L drink having a lower 
osmolality or there being too small a quantity of lipid to lead to significant delay 
in gastric emptying (Sidery et al., 1994; Vist and Maughan, 1995). Although 
contrary to our in vitro stability experiments, it is also possible that the CCD/L 
separated into lipid-depleted aqueous and lipid layers thereby allowing the 
lipid-depleted layer to empty rapidly (Marciani et al., 2006). Finally, the 
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behaviour of lipids ingested in the liquid phase may differ from those ingested in 
the solid phase (Cunningham and Read, 1989). A previous healthy volunteer 
study demonstrated little differences in the gastric emptying times of liquid 
isocaloric drinks that contained carbohydrate and those that additionally 
contained medium chain triglycerides (Vist and Maughan, 1995). However, the 
aforementioned study measured gastric emptying by the modified double 
sampling technique (Vist and Maughan, 1995) The novel findings from this 
scintigraphic study raise the possibility that the formulation and palatability of 
the carbohydrate-based preconditioning drinks currently administered to 
patients may be further improved by the addition of lipid thereby reducing 
osmolality and subsequent gastric emptying times whilst maintaining nutritional 
content. 
The postprandial glucose and insulin responses of CCD were similar to those 
demonstrated in Chapter 6 namely, a rapid peak in glucose and insulin 
concentrations occurring within 40 min followed by a rapid decline back to 
baseline concentrations over the subsequent hour. Postprandial glucose and 
insulin concentrations were highest following CCD (preOp®) probably as a result 
of it containing the greatest quantity of carbohydrate (50.4 g) compared to the 
other two drinks (36 g). Ingestion of glutamine blunted postprandial glucose 
and insulin responses, in line the study in chapter 6 where preOp® was 
compared to ONS. However, contrary to our previous hypotheses these blunted 
responses did not result from delayed gastric emptying. Furthermore, previous 
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human studies have demonstrated that glutamine supplementation increased 
postprandial and post-exercise insulin-mediated glucose disposal without 
elevating plasma insulin (Borel et al., 1998; Bowtell et al., 1999; Iwashita et al., 
2005; Iwashita et al., 2006). Increased glucose disposal following CCD/G 
ingestion could, therefore, have resulted in lower plasma glucose 
concentrations. The latter effect may be utilized perioperatively whereby 
preoperative ingestion of a glutamine-containing drink may act to modulate and 
increase glucose disposal, over and above a carbohydrate-only drink, thereby 
reducing postoperative insulin resistance. However, the latter hypothesis 
requires further study by means of a hyperinsulinaemic-euglycaemic clamp.  
Ingestion of the study drinks resulted in postprandial increases in plasma GLP-1, 
however, there were no differences in the magnitude of GLP-1 responses 
between the different drinks. A previous study that examined the effects of oral 
glutamine ingestion demonstrated increased postprandial GLP-1 concentrations 
associated with increased insulin concentrations (Greenfield et al., 2009). The 
aforementioned findings raised the possibility that oral glutamine may be used 
as a novel therapeutic approach to stimulate insulin secretion (Greenfield et al., 
2009). Within the context of preoperative conditioning using carbohydrate-
based drinks, the addition of glutamine would, therefore, have been expected to 
further augment insulin release over that achieved by carbohydrate loading 
alone. The results from the present study and that in Chapter 6 have failed to 
demonstrate this potentially beneficial metabolic effect of glutamine ingestion.  
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A potential limitation of this study was the use of corn oil which consisted of a 
mixture of polyunsaturated, monounsaturated and saturated fatty acids. The use 
of a purer preparation of a single chain length lipid would have improved the 
design of the study.  
In conclusion, this study has demonstrated that the addition of glutamine or lipid 
to a preoperative carbohydrate conditioning drink did not delay gastric 
emptying, but did blunt postprandial glucose and insulin responses. These 
effects were not related to differences in postprandial GLP-1 concentrations.  In 
addition, as all three drinks had a T90 of less than 2 hours, future patient studies 
should examine whether the addition of similar amounts of glutamine or lipid to 
clear carbohydrate drinks would allow for safe administration up to 2 hours 
preoperatively.
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Chapter 8 
Critique of thesis 
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Numerous scientific and clinical studies, undertaken in the last two decades, 
have demonstrated the beneficial effects of preoperative carbohydrate loading, 
as opposed to traditional preoperative fasting, in healthy non-diabetic patients 
undergoing elective surgery (Chapter 1). Ingestion of drinks containing 50 grams 
of carbohydrate, up to 90 min prior to induction of anaesthesia, attenuated the 
development of postoperative insulin resistance by up to 50% {Ljungqvist, 2004 
#643}. This was associated with improved postoperative whole-body protein 
balance (Svanfeldt et al., 2007), with better postoperative preservation of muscle 
mass (Yuill et al., 2005) and function (Henriksen et al., 2003), than in traditionally 
starved patients. Carbohydrate preconditioned patients also experienced less 
nausea, vomiting and anxiety perioperatively (Diks et al., 2005; Hausel et al., 
2005). Furthermore, retrospective analysis of a number of studies demonstrated 
shortened length of hospital stay (Thorell et al., 1999b) although this reduction 
was not statistically significant in a recent randomised controlled trial of patients 
undergoing elective colorectal and liver resections (Mathur et al., 2010). This 
intervention (preoperative conditioning with carbohydrate-based drinks) has 
been incorporated into enhanced recovery after surgery programs that aimed to 
minimise metabolic stress and speed recovery after major surgery (Lassen et al., 
2009). However, the cellular effects that underlie the adverse effects of 
preoperative fasting, and conversely, the beneficial effects of preoperative 
conditioning with carbohydrate-based drinks remained unknown.  
This thesis has demonstrated, using magnetic resonance spectroscopy, that 
ingestion of a preoperative carbohydrate-based conditioning drink, that also 
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contained glutamine and antioxidants (ONS), following a 24 hour fast repleted 
liver glycogen reserves by 47% within 2 hours of ingestion (Chapter 4). Whilst 
this physiologically beneficial effect could ensure the availability of easily 
utilisable energy reserves in times of increased need (Chapter 1), such as 
metabolic-stress following surgery, it is likely that these liver reserves would be 
depleted within 24 hours. Therefore increased liver glycogen per se is unlikely to 
contribute mechanistically to the marked attenuation of postoperative insulin 
resistance seen following preconditioning with carbohydrate-based drinks. The 
development of insulin resistance is more likely to occur secondary to alterations 
in skeletal muscle metabolism, given that muscle is the main site of glucose 
disposal following an oral carbohydrate load. In line with previous investigators 
(Briet and Jeejeebhoy, 2001; Briet et al., 2003b; Briet et al., 2003a; Briet et al., 
2004), we used PBMC mitochondrial membrane complex activity as a surrogate 
marker of what might occur in muscle following a 24-hour fast, followed by 
ingestion of a carbohydrate-based conditioning drink (ONS). Accordingly, we 
demonstrated that a 24-hour fast adversely affected PBMC MMC activity, 
resulting in significantly reduced MMC I (-72%), II (-49%) and IV (-41%) activities. 
We did not demonstrate that refeeding with the carbohydrate-based 
conditioning drink reversed these effects in PBMC mitochondria, however, the 
sampling time point chosen may not have been optimal. Similarly, the effects of 
this protocol on skeletal muscle MMC activity remain unknown  the latter 
would have required at least four sets of muscle biopsies within a period of 24-
hours which may have raised ethical concerns in this healthy volunteer study 
170 
(Chapter 4). Nonetheless, the novel finding of markedly decreased PBMC MMC 
activity after this short period of fasting (24 hours) may be of clinical significance 
should it result in weakened immune responses. Finally, this study also 
demonstrated a 23% increase in IMCL concentrations following a 24 hour fast. 
Volunteers were encouraged to drink water ad libitum so it is unlikely that 
alterations in muscle water concentrations would have resulted in a spurious 
result. Furthermore, previous investigators demonstrated a 175% increase in 
IMCL concentrations (Johnson et al., 2006) following a 67 hour fast  the latter 
correlating negatively with insulin sensitivity (measured by the intravenous 
glucose tolerance test). The mechanisms underlying this effect remain unclear. 
Elevated plasma FFA, seen following a prolonged period of fasting (Tsintzas et al., 
2007), are one of the determinants of the rate of muscle fat oxidation via the 
glucose-fatty acid cycle (Frayn, 1999). However, in healthy volunteers it would be 
expected that there would be sufficient mitochondrial capacity to oxidise 
increased concentrations of fatty acids, thereby limiting substantial elevations in 
IMCL concentrations. As previously described, the accumulation of IMCL 
metabolites could interfere with insulin signalling thereby inducing lipid-induced 
insulin resistance (Petersen and Shulman, 2006). However, it is of note that the 
latter hypothesis is based on studies of long-term IMCL elevation (such as in 
patients with type 2 diabetes), in contrast to the reversible effects reported in 
healthy volunteers following short-term fasting. Further studies would therefore 
be needed to characterise muscle mitochondrial complex activity, carbohydrate 
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and fat oxidative capacity following 12 and 24-hour fasts, followed by refeeding 
with these preconditioning drinks.  
In patients undergoing elective laparoscopic cholecystectomy, preoperative 
ingestion of a carbohydrate-based conditioning drink was well tolerated and 
resulted in increased intraoperative liver glycogen concentrations (Chapter 5). 
This study also demonstrated that the additional constituents (glutamine and 
antioxidants) were absorbed and led to increased plasma concentrations both 
intra- and postoperatively. Larger appropriately powered clinical studies would 
be needed to demonstrate whether preoperative ingestion of these additional 
conditioning agents (glutamine and antioxidants) resulted in clinical benefits 
(decreased morbidity or mortality). An improved experimental design would 
have investigated each component of the preconditioning drink (ONS) separately 
(carbohydrate versus glutamine versus antioxidants), however, the study in 
Chapter 5 was designed as a pilot study that would power future clinical studies 
investigating the clinical efficacy of preconditioning with ONS. Nevertheless, this 
study did reveal novel changes at the level of gene and protein expression. 
Preoperative conditioning with the carbohydrate-based drink resulted in a 4-fold 
and 44% lower expression of PDK4 mRNA and protein in the intervention group. 
A previous healthy volunteer study from our laboratory (Tsintzas et al., 2006) 
reported the effects of a 48-hour fast on PDK4 mRNA expression. In the 
aforementioned study a 48-hour fast resulted in a 4-fold higher expression of 
PDK4 mRNA compared to baseline (overnight fast). The placebo group in the 
patient study described in Chapter 5 would have encountered a degree of 
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metabolic-stress following a 12-18 hour period of fasting, anaesthetic induction, 
the insertion of laparoscopic ports and CO2 pneumoperitoneum. Even this 
magnitude of metabolic-stress resulted in significantly greater PDK4 mRNA and 
protein expression than that reported in the ONS-preconditioned group. PDK4 is 
one of the main regulators of PDC activity which plays a key role in muscle 
carbohydrate metabolism (Chapter 5). We demonstrated that the beneficial 
effects of preoperative carbohydrate loading were associated with lower PDK4 
expression which may have permitted PDC activity and carbohydrate oxidation. 
However, further studies need to examine how these intraoperative differences 
in the mechanisms regulating PDC activity lead to such marked reductions in 
postoperative insulin sensitivity. Future studies should also examine novel 
methods of optimising perioperative PDC activity with a view to maintaining 
carbohydrate oxidation in peripheral tissues. It is of note that there were no 
differences between the two groups (ONS and placebo) in mitochondrial 
function, as defined by MMC activity, β-HAD activity and ATP concentrations. 
However, it is possible that the intraoperative muscle sampling time point may 
have been too early to detect differences in mitochondrial enzyme activities (as 
changes were occurring at the level of gene and protein expression). Later 
sampling time points e.g. 12 and 24 hours postoperatively would have provided 
an elegant analysis of whether these changes at gene and protein expression 
translated to differences in enzyme activity. Finally, reduced cellular oxidative 
stress in the ONS-preconditioned group may have resulted from decreased FFA 
oxidation (reduced generation of ROS) or from the antioxidant constituents of 
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the drink. Future studies should determine the cellular and clinical relevance 
(decreased morbidity) of this finding. 
The aforementioned differences in gene and protein expression were 
demonstrated following preconditioning with ONS. It is possible, however, that 
ingestion of preOp® would have resulted in a greater magnitude of effects at 
gene and protein expression level, as a result of higher postprandial insulin and 
glucose concentrations (Chapter 6). Both drinks contained 50 grams of 
carbohydrate yet the postprandial glucose and insulin responses differed 
markedly. Ingestion of preOp® was associated with higher peaks in postprandial 
glucose and insulin concentrations, with concentrations decreasing rapidly to 
baseline within 80 min. In contrast, ONS ingestion was associated with blunted 
postprandial responses with concentrations of insulin remaining higher than 
preOp® at 100 min. These blunted postprandial responses may be clinically 
useful in patients with impaired glucose tolerance as the latter may not tolerate 
the rapid changes in glucose and insulin concentrations following preOp® (in 
several healthy volunteers postprandial blood glucose concentrations of 10-11 
mmol/L were recorded following preOp®).  
An elegant study by Svanfeldt et al (Svanfeldt et al., 2005) demonstrated that the 
preoperative serving of the carbohydrate-based drink increased peripheral 
insulin sensitivity by 50%. However, it remains unknown whether the beneficial 
effects of preconditioning with carbohydrate-based drinks arose from elevated 
insulin or glucose concentrations, or both, close to the onset of surgical stress. 
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Similarly, it remains to be known whether a minimal threshold of postprandial 
insulin release is required preoperatively to reduce postoperative insulin 
resistance. The study outlined in Chapter 6 demonstrated that 120 min after 
ingestion of both preconditioning drinks (ONS and preOp®), the clinical time 
point following which patients would undergo anaesthetic induction, 
postprandial insulin and glucose concentrations had returned to baseline. Thus 
any beneficial effects of preoperative carbohydrate loading using these drinks, 
demonstrated in previous studies, are unlikely to result from the presence of 
elevated insulin concentrations at the onset of surgical stress. It is of note, 
however, that the only study of preoperative carbohydrate loading per se to 
have demonstrated a near complete attenuation of the postoperative insulin 
resistance response (Nygren et al., 1998b) utilised a hyperinsulinaemic-
euglycaemic clamp. It is likely, therefore, that the mechanism of action of these 
preconditioning drinks is mainly via an insulin effect at the level of peripheral 
tissues (skeletal muscle). Further increasing endogenous insulin release, for 
example by means of an intraoperative infusion of 10% dextrose may lead to 
further attenuation of postoperative insulin resistance. Use of the latter would 
reduce the risk of thrombophlebitis (Chapter 1), but lead to sufficient release of 
endogenous insulin to stimulate carbohydrate oxidation.  
Ingestion of glutamine as part of a preconditioning regimen resulted in blunted 
glucose and insulin responses but did not, as hypothesised, delay gastric 
emptying (Chapter 7). The mechanisms underlying this effect of glutamine on 
insulin and glucose homeostasis are worthy of further study given that glutamine 
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supplementation resulted in improved metabolic control and decreased insulin 
resistance in critically ill patients (Dechelotte et al., 2006). Our study also 
demonstrated that glutamine ingestion, contrary to findings from a previous 
study (Greenfield et al., 2009), did not augment glucose-induced insulin release. 
The latter would have been a physiologically beneficial effect given the 
aforementioned discussion of the benefits of elevated perioperative insulin 
concentrations. Glutamine ingestion did, however, increase intraoperative 
plasma glutamine concentrations and tended to increase muscle glutamine 
reserves (Chapter 5) but further studies would be needed to investigate whether 
this leads to reduced morbidity in patients undergoing elective surgery. The 
blunted postprandial glucose responses may also have resulted from a 
glutamine-induced increase in glucose utilization {Iwashita, 2006 #577;Iwashita, 
2005 #786}, thereby reducing plasma glucose concentrations. The latter 
hypothesis if true, would increase glucose sensitivity over and above that 
achieved by carbohydrate loading alone, and this may result in reduced 
postoperative morbidity {Sato, 2010 #789}. 
Finally, the gastric emptying of these preconditioning drinks was more 
dependent on carbohydrate content than macronutrient composition (Chapter 
7). Contrary to current hypotheses (Houghton et al., 1990), the addition of lipid 
to the formulation of these drinks did not result in delayed gastric emptying. This 
raises the possibility of further optimising the designs of these drinks to optimise 
energy content, osmolality and palatability.  
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Chapter 9 
Future directions 
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The studies described in this thesis have helped define some of the mechanisms 
underlying the adverse effects of short-term fasting and beneficial effects of 
preoperative loading with carbohydrate-based drinks. However, the work 
undertaken thus far has also identified many new questions that we hope to 
address in future studies: 
1. Whether the decrease in mononuclear cell mitochondrial complex 
activity, following short-term fasting, leads to altered mononuclear cell 
function (e.g. NK cell activity or altered bacterial killing).  
2. Whether this decrease in mononuclear cell mitochondrial complex 
activity following short-term fasting also occurs in skeletal muscle 
mitochondria.  
3. The individual components of ONS (carbohydrate, glutamine and 
antioxidants) should be studied separately to ascertain the beneficial 
effects of each constituent and therefore further optimise these drinks. 
4. The effects of preoperative ingestion of carbohydrate drinks on PDC 
activity should be studied, along with the cellular and molecular 
pathways by which alterations in PDC activity leads to improved insulin 
sensitivity.  
5. New modalities of stimulating perioperative PDC activity, and therefore 
carbohydrate oxidation, should be studied. An example of such a novel 
modality includes intraoperative electrical stimulation of large muscle 
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groups (known to lead to intracellular calcium release, the latter a 
stimulant of PDC activity). 
6. Insulin clamp studies should be undertaken to determine whether there 
are differences in postprandial insulin sensitivity following the ingestion 
of preOp® and ONS and whether glutamine supplementation of these 
drinks increases glucose disposal over and above that by carbohydrate 
ingestion alone.  
7. The effects on postprandial glucose and insulin concentrations of the 
differing carbohydrate types contained in preOp® and ONS should be 
studied.  
8. New formulations of these preoperative drinks should utilise novel 
carbohydrates mixtures that are slowly broken down thereby leading to 
prolonged insulin release. 
9. Finally, the design and ingredients of these preoperative drinks could be 
further improved by including nutrients to improve caloric content and 
palatability. 
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Appendix A 
210 
Analysis and composition of standard meal ingested by volunteers in the study outlined in Chapter 4. Abbreviations: CHO  carbohydrate, 
BMR  basal metabolic rate (calculated from the Schofield equation (Schofield, 1985): RMR (age 18-30) = (0.063 x weight) + 2.896. RMR (age 30-60) = 
(0.048 x weight) + 3.653), RMR  resting metabolic rate, ERFD  Daily energy requirements calculated from 3-day food diary completed by the study 
participants the week prior to commencing the study, ERCALC - Daily energy requirement calculated from RMR assuming light level of activity (1.5 x 
BMR).   
 
 
Volunteer Number 
 1 2 3 4 5 6 7 8 9 10 11 12 
Age (years) 29 21 21 19 19 19 20 31 20 29 23 24 
Baseline weight 
(kg) 
63.3 61.1 72.6 83.7 83.5 63.7 70.8 68.3 72.5 80.6 74.3 93.8 
ERFD,  
kJ/day 
7969 9949 9365 7147 10791 7940 11417 8145 3518 13192 8192 9929 
BMR, 
kJ/day 
6883.9 6745.3 7469.8 8169.1 8156.5 6909.1 7356.4 6931.4 7463.5 7973.8 7576.9 8805.4 
ERCALC, 
kJ/day 
10326 10118 11205 12254 12235 10364 11035 10397 11195 11961 11365 13208 
Daily ERFD/ERCALC, 
% 
78 98 84 58 89 77 103 79 78 110 76 76 
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Composition of 
the standard 
meal  
Porridge (g) 120 160 125 120 160 120 160 120 120 180 100 160 
Sugar (g) 30 48 45 25 60 35 65 40 40 82 36 50 
Cream (g) 22.5 45 30 15 52.5 22.5 54 24 26 56 26 45 
Whey protein (g) 15 20 19 10 25 15 27 15 17 30 17 20 
Milk (ml) 200 225 250 250 200 215 250 215 225 300 250 250 
Slices of bread 2 2 2 2 2 2 2 2 2 2 2 2 
Jam (g) 30 48 30 18 30 18 30 16.5 27 30 30 26 
Butter 
2 x 
thinly 
spread 
2 x 
thinly 
spread 
2 x 
thinly 
spread 
2 x 
thinly 
spread 
1 x 
thinly 
spread 
2 x 
thinly 
spread 
2 x 
thinly 
spread 
2 x 
thinly 
spread 
2 x 
thinly 
spread 
2x 
thickly 
spread 
2 x 
thinly 
spread 
2 x thinly 
spread 
Energy kJ 
(kCal) 
3202 
759 
3956 
939 
3777 
896 
2858 
678 
4340 
1030 
3176 
754 
4548 
1088 
3280 
778 
3494 
829 
5277 
1255 
3470 
823 
3996 
948 
Total CHO (g) 102.05 125.75 102.68 91.26 137.30 99.73 144.93 103.97 111.72 166.78 109.14 126.44 
Total fat (g) 29.48 36.67 34.42 26.29 40.28 29.73 41.94 30.54 31.92 50.01 32.13 37.09 
Total protein 
(g) 
28.23 34.60 33.83 25.11 38.51 28.67 42.09 28.69 30.98 46.92 31.57 35.43 
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